header|cdr_l1|l1_bestgerm|l1_germdist|fw_l1|l1f_bestgerm|l1f_germdist|cdr_l2|l2_bestgerm|l2_germdist|fw_l2|l2f_bestgerm|l2f_germdist
>abagovomab_VL|QASENIYSYLA|IGKV1-8/IGKV1-9|4|DIELTQSPASLSASVGETVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|5|NAKTLAG|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WHQQKQGKSPQLLVY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|5
>abciximab_VL|RASRDISNNLH|IGKV1-16/IGKV1-27|4|EIVLTQSPVTLSVTPGDSVSLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|7|YASQSMS|IGKV6-21/IGKV6D-21|1|WFQQTSHESPRLLIK|IGKV2-30/IGKV2D-30|6
>abelacimab_VL|SGSSSNIGSNDVS|IGLV1-44|2|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|KNYNRPS|IGLV1-40|2|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>abiprubart_VL|SASSSVSYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGQAPRRWIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|2
>abituzumab_VL|RASQDISNYLA|IGKV1-16/IGKV1-27|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSKIHS|IGLV7-43|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>abrezekimab_VL|LASEDISNYLA|IGKV1-16/IGKV1-27|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|HTSRLQD|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>abrilumab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|GASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>acapatamab_VL|KASQNVDTNVA|IGKV3-15/IGKV3D-15|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYVYW|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|5|WYQQKPGQAPKSLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>acapatamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>acasunlimab_VL|GGNNIGSKSVH|IGLV3-21|0|SYVLTQPPSVSVAPGQTARITC|IGLV3-21|1|DDNDRPS|IGLV1-51|2|WYQQKPGQAPVLVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>acasunlimab_VL_1|QASEDISSYLA|IGKV1-33/IGKV1D-33|3|DIVMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|GASDLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKRLIY|IGKV1-17|0
>acimtamig_VL|GGHNIGSKNVH|IGLV3-9|1|SYVLTQPSSVSVAPGQTATISC|IGLV3-21|4|QDNKRPS|IGLV3-1|1|WYQQRPGQSPVLVIY|IGLV3-1|1
>acimtamig_VL_1|KASQNVGTNVA|IGKV3-15/IGKV3D-15|5|DIVMTQSPKFMSTSVGDRVTVTC|IGKV1-12/IGKV1D-12|6|SASYRYS|IGKV2-40/IGKV2D-40|3|WFQQKPGQSPKVLIY|IGKV1-16|3
>acrixolimab_VL|RSSQSLLDSEDGNTYLD|IGKV2-40/IGKV2D-40|1|DIVMTQTPLSLPVTPGEAASISC|IGKV2-40/IGKV2D-40|1|TLSHRAS|IGKV2-40/IGKV2D-40|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>actoxumab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQHKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>adalimumab_VL|RASQGIRNYLA|IGKV1-16/IGKV1-27|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>adebrelimab_VL|RASESVSIHGTHLMH|||DIVLTQSPASLAVSPGQRATITC|IGKV4-1|5|AASNLES|IGKV1-NL1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>adecatumumab_VL|RTSQSISSYLN|IGKV1-39/IGKV1D-39|1|ELQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>adintrevimab_VL|TGSSSNIGAGYDVH|IGLV1-40|0|QSVLTQPPSVSGAPGQRITISC|IGLV1-40|1|GSSSRNS|IGKV3-20|3|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>aducanumab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>afasevikumab_VL|RASQSVRSYLA|IGKV3-11|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>alacizumab_VL|RASQDIAGSLN|IGKV1-33/IGKV1D-33|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|ATSSLDS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WLQQKPGKAIKRLIY|IGKV1-17|2
>alemtuzumab_VL|KASQNIDKYLN|IGKV1-33/IGKV1D-33|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NTNNLQT|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>alextatug_VL|SGSSSNIGSSSVS|IGLV1-44|3|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|KNNQRPS|IGLV1-44|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>alirocumab_VL|KSSQSVLYRSNNRNFLG|IGKV4-1|4|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPNLLIY|IGKV4-1|1
>alnuctamab_VL|RASQSVSDEYLS|IGKV3D-7|2|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|SASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|1|WYQQKPGQAPRLLIH|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>alnuctamab_VL_1|GSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQEKPGQAFRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|5
>alomfilimab_VL|RASQSVSRSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKRGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>alsevalimab_VL|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>amatuximab_VL|SASSSVSYMH|||DIELTQSPAIMSASPGEKVTMTC|IGKV1-9|8|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKSGTSPKRWIY|IGKV1-17|4
>amivantamab_VL|RASQDISSALV|IGKV1D-13|2|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|DASSLES|IGKV1-5/IGKV1D-13|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>amivantamab_VL_1|RASQGISNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLLS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WFQHKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>amlitelimab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPNLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>amubarvimab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>anbenitamab_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>anbenitamab_VL_1|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>andecaliximab_VL|KASQDVRNTVA|IGKV1-16/IGKV1-27|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SSSYRNT|IGKV2-40/IGKV2D-40|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>anetumab_VL|TGTSSDIGGYNSVS|IGLV2-11/IGLV2-14/IGLV2-8|2|DIALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|2|GVNNRPS|IGLV3-19|1|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>anifrolumab_VL|RASQSVSSSFFA|IGKV3-20|2|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>anivovetmab_VL|KASQNVDSNVD|IGKV3-15/IGKV3D-15|5|DIVMTQTPASMSISVGDRVTMNC|IGKV1-12/IGKV1D-12|7|KASNRNT|IGKV3-11/IGKV3D-11|2|WYQQKTGQSPNLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|3
>anrukinzumab_VL|KASESVDNYGKSLMH|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|RASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>anselamimab_VL|RSSQSLVHRNGNTYLH|IGKV2-24|3|DVVMTQTPLSLPVSLGDQASISC|IGKV2-30/IGKV2D-30|4|KVSNRFS|IGKV2-24|1|WYLQKPGQSPKLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>ansuvimab_VL|RASQAFDNYVA|IGKV1-16/IGKV1-27|4|DIQMTQSPSSLSASVGDRITITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASALHA|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQRPGKVPKLLIS|IGKV1-27|2
>anumigilimab_VL|RASQGISSYLN|IGKV1-39/IGKV1D-39|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YASNLQN|IGKV1D-43|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>anvatabart_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>anzurstobart_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASNLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>apamistamab_VL|RASKSVSTSGYSYLH|||DIALTQSPASLAVSLGQRATISC|IGKV4-1|5|LASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>apitegromab_VL|SGSSSNIGSNTVH|IGLV1-44|1|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|SDNQRPS|IGLV1-44|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>aprutumab_VL|SGSSSNIGNNYVS|IGLV1-51|0|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|ENYNRPA|IGLV1-40|3|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>arcitumomab_VL|RASSSVTYIH|||QTVLSQSPAILSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|9|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGSSPKSWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>ascrinvacumab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GTSSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>aselizumab_VL|KASQSVDYDGDSYMN|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASNLES|IGKV1-NL1|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>astegolimab_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>atezolizumab_VL|RASQDVSTAVA|IGKV1D-13|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>atibuclimab_VL|RASESVDSYVNSFLH|||DIVLTQSPASLAVSLGQRATISC|IGKV4-1|4|RASNLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>atidortoxumab_VL|RASQGISRWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>atinumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>atisnolerbart_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>atoltivimab_VL|RASQSISTYLH|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRITITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>avdoralimab_VL|RASQSVSSRYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>avelumab_VL|TGTSSDVGGYNYVS|IGLV2-11/IGLV2-14/IGLV2-8|0|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|DVSNRPS|IGLV2-11|1|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>avizakimab_VL|RASQDISNFLN|IGKV1-33/IGKV1D-33|2|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|YTSRLHS|IGKV1-NL1|3|WYQQKPGKAVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>axatilimab_VL|LASEDIYDNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YASSLQD|IGKV1D-43|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>azintuxizumab_VL|RSSQSLVHSNGNTYLH|IGKV2-24|2|DVVMTQTPLSLSVTPGQPASISC|IGKV2D-29|1|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>bafisontamab_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bafisontamab_VL_1|RASQGINTWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|2|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLKS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>balstilimab_VL|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>bamlanivimab_VL|RASQSISSYLS|IGKV1-39/IGKV1D-39|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bapineuzumab_VL|KSSQSLLDSDGKTYLN|IGKV2D-29|2|DVVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|1|LVSKLDS|IGKV2-30|3|WLLQKPGQSPQRLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>bapotulimab_VL|RSSQSLLYSNGYNYLD|IGKV2-28/IGKV2D-28|1|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|LGSNRAS|IGKV2-28/IGKV2D-28|0|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>barecetamab_VL|SGSSSNIGSNSVS|IGLV1-44|2|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|SDNHRPS|IGLV1-44|2|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>barzolvolimab_VL|KASQNVRTNVA|IGKV3-15/IGKV3D-15|5|DIVMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGKAPKALIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>basiliximab_VL|SASSSRSYMQ|||QIVSTQSPAIMSASPGEKVTMTC|IGKV1D-17|9|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGTSPKRWIY|IGKV1-17|3
>batoclimab_VL|GGNNIGSKSVH|IGLV3-21|0|SYVLTQSPSVSVAPGQTARITC|IGLV3-21|2|DDSDRPS|IGLV3-21|1|WYQQKPGQAPVLVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>bavituximab_VL|RASQDIGSSLN|IGKV6-21/IGKV6D-21|2|DIQMTQSPSSLSASLGERVSLTC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|ATSSLDS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WLQQGPDGTIKRLIY|IGKV1-17|6
>bavunalimab_VL|RASQSVDYDGDSYMN|||DIVLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|AASELES|IGKV1-NL1|1|WYQQKPGKPPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>bavunalimab_VL_1|RASQSVGSSYLA|IGKV3-20|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>bebtelovimab_VL|TATSSDVGDYNYVS|IGLV2-11/IGLV2-14/IGLV2-8|2|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|EVSDRPS|IGLV2-14/IGLV2-18|1|WYQQHPGKAPKLMIF|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|1
>becotatug_VL|RASQSIGTNIH|IGKV6-21/IGKV6D-21|3|EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|YASESIS|IGKV6-21/IGKV6D-21|2|WYQQKPDQSPKLLIK|IGKV6-21/IGKV6D-21|0
>bedinvetmab_VL|SGSTNNIGILGAS|IGLV1-51|6|QSVLTQPTSVSGSLGQRVTISC|IGLV1-40|3|GNGNRPS|IGLV1-40|1|WYQLFPGKAPKLLVY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>befovacimab_VL|SGDNLPKYYAH|IGLV3-10|3|SYELTQPPSVSVSPGQTARITC|IGLV3-10|0|YDVNRPS|IGLV3-12|2|WYQQKPGQAPVVVIF|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|2
>begelomab_VL|SASSSVSYMN|||QIVLTQSPAIMSASPGEKVTITC|IGKV6-21/IGKV6D-21|7|STSNLAS|IGLV7-43|2|WFQQKPGTSPKLWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>belantamab_VL|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSNLHS|IGLV7-43|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>belimumab_VL|QGDSLRSYYAS|IGLV3-19|0|SSELTQDPAVSVALGQTVRVTC|IGLV3-19|1|GKNNRPS|IGLV3-19|0|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>belrestotug_VL|RASQSVRSSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>beludavimab_VL|RASQTVSSTSLA|IGKV3-20|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>bemarituzumab_VL|KASQGVSNDVA|IGKV1-16/IGKV1-27|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bempikibart_VL|RASQGISSALA|IGKV1D-13|0|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|DASSLES|IGKV1-5/IGKV1D-13|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>benmelstobart_VL|KASQSVSNDVA|IGKV3-11|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YAANRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>benralizumab_VL|GTSEDIINYLN|IGKV1-33/IGKV1D-33|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|HTSRLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bentracimab_VL|SGSNSDIGNNYVS|IGLV1-51|2|QSVVTQPPSVSAAPGQKVTISC|IGLV1-51|1|DNNKRPS|IGLV1-51|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>benufutamab_VL|RASQSISNNLH|IGKV1-16/IGKV1-27|3|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|FASQSIT|IGKV6-21/IGKV6D-21|3|WYQQKPGQAPRLLIK|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>bepranemab_VL|RSSQSLEYSDGYTYLE|IGKV2-30/IGKV2D-30|3|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|EVSNRFS|IGKV2D-26/IGKV2D-29|0|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>berlimatoxumab_VL|RASQSINSYLN|IGKV1-39/IGKV1D-39|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bermekimab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|EASNLET|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bersanlimab_VL|TGSSSNIGAGYDVH|IGLV1-40|0|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|DNNNRPS|IGLV1-51|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>betifisolimab_VL|RASESVDIYGNSFMH|||DIVLTQSPASLAVSVGQRATITC|IGKV4-1|5|RASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>bevacizumab_VL|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|FTSSLHS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>bexmarilimab_VL|TASSSVSSSYLH|IGKV3-20|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|RTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bezetabart_VL|RASQGIGSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AADRLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bezlotoxumab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>bifikafusp_VL|RASQSVSSSFLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|YASSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>bimagrumab_VL|TGTSSDVGSYNYVN|IGLV2-11/IGLV2-14/IGLV2-8|2|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|GVSKRPS|IGLV2-11|1|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>bimekizumab_VL|RADESVRTLMH|IGKV3-11|7|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|LVSNSEI|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bintrafusp_VL|TGTSSDVGGYNYVS|IGLV2-11/IGLV2-14/IGLV2-8|0|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|DVSNRPS|IGLV2-11|1|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>birtamimab_VL|RSSQSLVHSTGNTYLH|IGKV2-24|2|DVVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|1|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>bleselumab_VL|RASQGISSALA|IGKV1D-13|0|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|DASNLES|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>blinatumomab_VL|KASQSVDYDGDSYLN|||DIQLTQSPASLAVSLGQRATISC|IGKV4-1|5|DASNLVS|IGKV1-33/IGKV1D-33|2|WYQQIPGQPPKLLIY|IGKV4-1|1
>blinatumomab_VL_1|RASSSVSYMN|||DIQLTQSPAIMSASPGEKVTMTC|IGKV1-9|7|DTSKVAS|IGLV2-11|3|WYQQKSGTSPKRWIY|IGKV1-17|4
>blontuvetmab_VL|KSSQSLLYSGNQKNYLA|IGKV4-1|3|DVVMSQSPSSLAVSVGEKVTMSC|IGKV4-1|8|WASTRES|IGKV4-1|0|WYQQKPGQSPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>blosozumab_VL|KASQDVHTAVA|IGKV1D-13|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASTRWT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>bococizumab_VL|RASQGISSALA|IGKV1D-13|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>boserolimab_VL|SASSSVSYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGQAPKRWIY|IGKV1-17|2
>botensilimab_VL|RASQSVSRYLG|IGKV3-11|2|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>brazikumab_VL|TGSSSNTGAGYDVH|IGLV1-40|1|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|GSGNRPS|IGLV1-40|2|WYQQVPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|1
>bremzalerbart_VL|RASQSIKSFLA|IGKV1-5|2|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRPT|IGKV3-11/IGKV3D-11|1|WYRQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>brenetafusp_VL|RASQDIRNYLN|IGKV1-33/IGKV1D-33|2|AIQMTQSPSSLSASVGDRVTITC|IGKV1-6|0|YTSRLES|IGKV1-NL1|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>brentuximab_VL|KASQSVDFDGDSYMN|||DIVLTQSPASLAVSLGQRATISC|IGKV4-1|4|AASNLES|IGKV1-NL1|1|WYQQKPGQPPKVLIY|IGKV4-1|1
>briakinumab_VL|SGSRSNIGSNTVK|IGLV1-44|2|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|YNDQRPS|IGLV1-44|2|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>briquilimab_VL|RASESVDIYGNSFMH|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|LASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>brodalumab_VL|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|DASTRAT|IGKV3-11/IGKV3D-11|1|WFQQKPGQAPRPLIY|IGLV7-43|1
>brolucizumab_VL|QASEIIHSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|EIVMTQSPSTLSASVGDRVIITC|IGKV1-5|3|LASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>brontictuzumab_VL|RSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNNRAP|IGLV3-19|3|WFQQKPGQAPRTLIG|IGLV7-46|1
>budigalimab_VL|RSSQSIVHSHGDTYLE|IGKV2-24|4|DVVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|1|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>budoprutug_VL|SASSGVNYMH|||QIVLTQSPATLSASPGEKATMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|5|DTDKTAS|IGLV1-51|4|WYQQKPGTSPKRWIY|IGKV1-17|3
>burfiralimab_VL|RASENIYSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|VADNLAD|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>burosumab_VL|RASQGISSALV|IGKV1D-13|1|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|DASSLES|IGKV1-5/IGKV1D-13|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>cabiralizumab_VL|KASQSVDYDGDNYMN|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|AASNLES|IGKV1-NL1|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>cabotamig_VL|RASQDISGYLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|TTSTLDS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WLQQKPGGAIKRLIY|IGKV1-17|3
>cabotamig_VL_1|RASQDIRNYLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLES|IGKV1-NL1|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>cadonilimab_VL|RASQDINTYLS|IGKV1-16/IGKV1-27|4|DIQMTQSPSSMSASVGDRVTFTC|IGKV1-12/IGKV1D-12|2|RANRLVS|IGKV1-NL1|3|WFQQKPGKSPKTLIY|IGKV1-16|2
>cadonilimab_VL_1|GSSTGAVTTSNFPN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNNKAS|IGLV3-19|3|WVQQKPGQAPRSLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>calpurbatug_VL|RASQRLGGTSLA|IGKV3-20|6|DIVLTQAPGTLSLSPGDRATLSC|IGKV3-20|3|GTSNRAT|IGKV3-11/IGKV3D-11|2|WYQHRSGQAPRLILY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|5
>camidanlumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>camoteskimab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASTLES|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>camrelizumab_VL|LASQTIGTWLT|IGKV1-12/IGKV1D-12/IGKV1D-16|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|TATSLAD|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>canakinumab_VL|RASQSIGSSLH|IGKV6-21/IGKV6D-21|0|EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|YASQSFS|IGKV6-21/IGKV6D-21|0|WYQQKPDQSPKLLIK|IGKV6-21/IGKV6D-21|0
>canrivitug_VL|TGSSSNIGTHYDVH|IGLV1-40|2|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|GNSNRPS|IGLV1-40|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>cantuzumab_VL|RSSKSLLHSNGNTYLY|IGKV2D-26|3|DIVMTQSPLSVPVTPGEPVSISC|IGKV2-28/IGKV2D-28|2|RMSNLVS|IGLV3-9|3|WFLQRPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>carlumab_VL|RASQSVSDAYLA|IGKV3-20|2|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASSRAT|IGKV3D-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>carotuximab_VL|RASSSVSYMH|||QIVLSQSPAILSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGSSPKPWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>casdozokitug_VL|KSSQSVLFSSNNKNYLA|IGKV4-1|1|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>cemavafusp_VL|SASSSVSYMY|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|LTSNLAS|IGKV2-28/IGKV2D-28|2|WYQQKPRSSPKPWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|5
>cemiplimab_VL|RASLSINTFLN|IGKV1-39/IGKV1D-39|4|DIQMTQSPSSLSASVGDSITITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|AASSLHG|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WYQQKPGKAPNLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>cendakimab_VL|RASQDIRNYLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTISC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|YTSKLHS|IGKV1D-43|3|WYQQKPGKAPKLLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>cepeprubart_VL|RSSRSLVHSNGNTYLH|IGKV2-24|3|DIVMTQTPLSLPVTPGEPASISC|IGKV2-40/IGKV2D-40|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>cergutuzumab_VL|KASAAVGTYVA|IGKV3-11|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRKR|IGKV2-40/IGKV2D-40|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>certolizumab_VL|KASQNVGTNVA|IGKV3-15/IGKV3D-15|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKALIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>cetrelimab_VL|RASQSVRSYLA|IGKV3-11|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>cetuximab_VL|RASQSIGTNIH|IGKV6-21/IGKV6D-21|3|DILLTQSPVILSVSPGERVSFSC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|YASESIS|IGKV6-21/IGKV6D-21|2|WYQQRTNGSPRLLIK|IGKV6-21/IGKV6D-21|5
>cevostamab_VL|KASQDVRNLVV|IGKV1-17/IGKV1-6|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SGSYRYS|IGKV2-28/IGKV2D-28|3|WFQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>cevostamab_VL_1|KSSQSLLNSRTRKNYLA|IGKV4-1|5|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WTSTRKS|IGKV4-1|2|WYQQKPGQSPKLLIY|IGKV4-1|1
>cibisatamab_VL|KASAAVGTYVA|IGKV3-11|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRKR|IGKV2-40/IGKV2D-40|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>cibisatamab_VL_1|GSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQEKPGQAFRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|5
>ciduvectamig_VL|RASQGIRNDLG|IGKV1-17/IGKV1-6|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ciduvectamig_VL_1|TGTSSNIGTYKFVS|IGLV2-11/IGLV2-14/IGLV2-8|5|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|EVSKRPS|IGLV2-8|0|WYQQHPDKAPKVLLY|IGKV1-NL1|3
>cifurtilimab_VL|RSSQSLVHSNGNTFLH|IGKV2-24|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|TVSNRFS|IGKV2D-26/IGKV2D-29|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>cilgavimab_VL|KSSQSVLYSSNNKNYLA|IGKV4-1|0|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLMY|IGKV4-1|1
>cinpanemab_VL|SGEALPMQFAH|IGLV3-16|4|SYELTQPPSVSVSPGQTARITC|IGLV3-10|0|KDSERPS|IGLV3-16/IGLV3-25/IGLV3-27|0|WYQQRPGKAPVIVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|4
>cinrebafusp_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>cirevetmab_VL|RASENIYSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|EIVMTQSPASLSLSQGEKVTITC|IGKV3D-7|6|AATNLAD|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQQRPGQAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>citatuzumab_VL|RSTKSLLHSNGITYLY|IGKV2D-26|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|QMSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>cixutumumab_VL|QGDSLRSYYAT|IGLV3-19|1|SSELTQDPAVSVALGQTVRITC|IGLV3-19|0|GENKRPS|IGLV1-51|2|WYQQKPGQAPILVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>clazakizumab_VL|QASQSINNELS|IGKV1-33/IGKV1D-33|4|AIQMTQSPSSLSASVGDRVTITC|IGKV1-6|0|RASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>clervonafusp_VL|RASKSVSTSSYSYMH|||DIQMTQSPSSLSASVGDRVTISC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|YASYLQS|IGKV1D-43|1|WYQQKPEKAPKLLIK|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>clesrovimab_VL|RTSQDVRGALA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASSLET|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>clivatuzumab_VL|SASSSVSSSYLY|IGKV3-20|3|DIQLTQSPSSLSASVGDRVTMTC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|STSNLAS|IGLV7-43|2|WYQQKPGKAPKLWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>cobolimab_VL|RASQSIRRYLN|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYHQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>codrituzumab_VL|RSSQSLVHSNRNTYLH|IGKV2-24|3|DVVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|1|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>cofetuzumab_VL|RASESVDSYGKSFMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|RASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>coltuximab_VL|SASSGVNYMH|||EIVLTQSPAIMSASPGERVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|6|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGTSPRRWIY|IGKV1-17|4
>conatumumab_VL|RASQGISRSYLA|IGKV3-20|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPSLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>concizumab_VL|KSSQSLLESDGKTYLN|IGKV2D-29|2|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|LVSILDS|IGKV2-30|3|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>coprelotamab_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>coramitug_VL|RSSKSLLHSNGNTYLY|IGKV2D-26|3|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|RVSNLAS|IGKV2-28/IGKV2D-28|3|WFLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>cosfroviximab_VL|KASQNVGTAVA|IGKV1D-13|6|DIVMTQSPLSLSTSVGDRVSLTC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|5|SASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPGQSPKLLIY|IGKV4-1|1
>cosibelimab_VL|TRSSGSIDSNYVQ|IGLV6-57|1|NFMLTQPHSVSESPGKTVTISC|IGLV6-57|0|EDNQRPS|IGLV6-57|0|WYQQRPGSAPTTVIY|IGLV6-57|1
>crefmirlimab_VL|RTSRSISQYLA|IGKV1-16/IGKV1-27|4|DVQITQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|SGSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKVPKLLIY|IGKV1-27|0
>crenezumab_VL|RSSQSLVYSNGDTYLH|IGKV2-30/IGKV2D-30|3|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>crexavibart_VL|TGTSSDVGGYNYVS|IGLV2-11/IGLV2-14/IGLV2-8|0|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|DVSNRPS|IGLV2-11|1|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>crizanlizumab_VL|KASQSVDYDGHSYMN|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASNLES|IGKV1-NL1|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>crotedumab_VL|RASQGIRNDLG|IGKV1-17/IGKV1-6|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKRLIY|IGKV1-17|0
>crovalimab_VL|RASQGISSSLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASETES|IGKV1-5/IGKV1D-13|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>cudarolimab_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>cusatuzumab_VL|GLKSGSVTSDNFPT|IGLV8-61|7|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|NTNTRHS|IGLV8-61|2|WYQQTPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>dacetuzumab_VL|RSSQSLVHSNGNTFLH|IGKV2-24|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|TVSNRFS|IGKV2D-26/IGKV2D-29|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>daclizumab_VL|SASSSISYMH|||DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|TTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>dafsolimab_VL|SASSSVSYMH|||QIVLTQSPAIMSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKSGTSPKRWIY|IGKV1-17|4
>dalnicastobart_VL|RASQGIYSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|TASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQKPGKAPNLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>dalotuzumab_VL|RSSQSIVHSNGNTYLQ|IGKV2-24|3|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|KVSNRLY|IGKV2-30|2|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>dalutrafusp_VL|RASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLHS|IGKV1-NL1|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>danburstotug_VL|GGENIGRKTVH|IGLV3-12|3|SYVLTQPPSVSVAPGKTATIAC|IGLV3-21|2|YDSDRPS|IGLV3-21|0|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>danvilostomig_VL|RASQSVGSSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GAFSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>danvilostomig_VL_1|QASQNIYSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|ALVMTQSPSSLSASVGDRVTITC|IGKV1-6|2|QASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKVPKLLIY|IGKV1-27|0
>dapirolizumab_VL|RASEDLYYNLA|IGKV3-15/IGKV3D-15|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DTYRLAD|IGKV1-33/IGKV1D-33|5|WYQRKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>daratumumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>dargistotug_VL|RASQGISSYLA|IGKV1-8/IGKV1-9|0|DIQLTQSPSFLSASVGDRVTITC|IGKV1-9|0|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>datopotamab_VL|KASQDVSTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>davutamig_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>davutamig_VL_1|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>daxdilimab_VL|TGTSSDVGGYNYVS|IGLV2-11/IGLV2-14/IGLV2-8|0|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|DVSNRPS|IGLV2-11|1|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>dazukibart_VL|RTSQDIGNYLN|IGKV1-33/IGKV1D-33|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|STSRLHS|IGLV7-43|2|WYQQKPGKAFKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>dectrekumab_VL|RAGQSVSSYLV|IGKV3-11|2|EIVLTQSPATLSLSPGERAILSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>delpacibart_VL|RTSENIYNNLA|IGKV1-16/IGKV1-27|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AATNLAD|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQQKPGKSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>demcizumab_VL|RASESVDNYGISFMK|||DIVMTQSPDSLAVSLGERATISC|IGKV4-1|1|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGQPPKLLIY|IGKV4-1|1
>demupitamab_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>denecimig_VL|RASQSISSWLA|IGKV1-5|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASKLER|IGKV1-33/IGKV1D-33|3|WYQQKPGKAPKFLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>denecimig_VL_1|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GQSSRTR|IGKV3-20|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>denintuzumab_VL|SASSSVSYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>denosumab_VL|RASQSVRGRYLA|IGKV3-20|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>depatuxizumab_VL|HSSQDINSNIG|IGKV1-12/IGKV1D-12/IGKV1D-16|7|DIQMTQSPSSMSVSVGDRVTITC|IGKV1-12/IGKV1D-12|2|HGTNLDD|IGKV1-33/IGKV1D-33|5|WLQQKPGKSFKGLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>depemokimab_VL|KSSQSLLNSGNQKNYLA|IGKV4-1|4|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|GASTRES|IGKV4-1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>derlotuximab_VL|RASSSVSSSYLH|IGKV3-20|2|ENVLTQSPAIMSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|STSNLAS|IGLV7-43|2|WYQQKSGASPKLWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>devextinetug_VL|SASSSVSSRYLY|IGKV3-20|4|QIVLIQSPPIMSASPGEKVTLTC|IGKV3-11/IGKV3D-11/IGKV3D-20|9|GTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGSSPKLWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>dezamizumab_VL|RASENIYSYLA|IGKV1-8/IGKV1-9|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NAKTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGKAPKLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>dilpacimab_VL|RASEDIYSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DTNNLAD|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>dilpacimab_VL_1|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|FTSSLHS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>dinutuximab_VL|RSSQSLVHRNGNTYLH|IGKV2-24|3|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPKLLIH|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>diridavumab_VL|SGSSSNIGNDYVS|IGLV1-51|1|QSVLTQPPSVSAAPGQKVTISC|IGLV1-51|0|DNNKRPS|IGLV1-51|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>disitamab_VL|KASQDVGTAVA|IGKV1D-13|6|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|WASIRHT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>divozilimab_VL|RASSSVSYIH|||QIVLSQSPAILSASPGERVTLTC|IGKV3-11/IGKV3D-11/IGKV3D-20|6|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGKAPKPLIY|IGKV1-16|1
>docaravimab_VL|RPSQDINNYLS|IGKV1-16/IGKV1-27|4|DVQMTQTTSSLSASLGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|YTSRLHS|IGKV1-NL1|3|WYQQKPDGTVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>domagrozumab_VL|KASQDVSTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>domvanalimab_VL|RASKSISKYLA|IGKV1-16/IGKV1-27|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SGSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>donanemab_VL|KSSQSLLYSRGKTYLN|IGKV2D-29|3|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|AVSKLDS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WLLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>donzakimig1_VL|QASEDIYTNLA|IGKV1-33/IGKV1D-33|5|AVQLTQSPSSLSASVGDRVTITC|IGKV1D-13|1|WASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>donzakimig1_VL_1|QSSPSVWSNFLS|IGKV3D-7|6|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|EASKLTS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>donzakimig2_VL|KASQNINENLD|IGKV1-12/IGKV1D-12/IGKV1D-16|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTDILQT|IGKV1D-43|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>dostarlimab_VL|KASQDVGTAVA|IGKV1D-13|6|DIQLTQSPSFLSAYVGDRVTITC|IGKV1-9|1|WASTLHT|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>dovanvetmab_VL|RASQGISIWLS|IGKV1-12/IGKV1D-12/IGKV1D-16|2|EIQMTQSPSSLSASPGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|KASNLHI|IGKV1-33/IGKV1D-33|3|WYQQKPGNIPKVLIN|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>dresbuxelimab_VL|KSSQSLLNSSNQKNYLA|IGKV4-1|3|DIVMTQSPSSLAVSVGERVTISC|IGKV4-1|4|FASTRES|IGKV4-1|1|WYQQKPGQAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>drozitumab_VL|SGDSLRSYYAS|IGLV3-19|1|SELTQDPAVSVALGQTVRITC|||GANNRPS|IGLV3-19|1|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>duligotuzumab_VL|RASQNIATDVA|IGKV1-12/IGKV1D-12/IGKV1D-16|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>dupilumab_VL|RSSQSLLYSIGYNYLD|IGKV2-28/IGKV2D-28|2|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|LGSNRAS|IGKV2-28/IGKV2D-28|0|WYLQKSGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>durvalumab_VL|RASQRVSSSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|DASSRAT|IGKV3D-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>dusigitumab_VL|SGSSSNIENNHVS|IGLV1-51|2|QSVLTQPPSVSAAPGQKVTISC|IGLV1-51|0|DNNKRPS|IGLV1-51|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>duvakitug_VL|TSSSSDIGAGLGVH|IGLV1-40|4|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|GYYNRPS|IGLV1-40|2|WYQQLPGTAPKLLIE|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|1
>duvortuxizumab_VL|RASQSVSYMH|||ENVLTQSPATLSVTPGEKATITC|IGKV3-11/IGKV3D-11/IGKV3D-20|6|DASNRAS|IGKV3-11/IGKV3D-11|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>duvortuxizumab_VL_1|RSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>ebdarokimab_VL|RASQSVGTWVA|IGKV1-5|4|EIVLTQSPATLSASPGERATISC|IGKV3-11/IGKV3D-11/IGKV3D-20|2|AASNLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGQAPRSLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>eblasakimab_VL|RASQSISSSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ebronucimab_VL|TGTSRNIGGGNDVH|IGLV1-40|4|QSELTQPRSVSGSPGQSVTISC|IGLV2-11|1|GVIERSS|IGKV2-30|4|WYQQHPGKAPKLLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>eciskafusp_VL|KASESVDTSDNSFIH|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|RSSTLES|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGQSPKLLIY|IGKV4-1|1
>ecleralimab_VL|SGDNIGSKYVH|IGLV3-12|3|SYELTQPLSVSVALGQTARITC|IGLV3-9|0|GDNERPS|IGLV3-16/IGLV3-25/IGLV3-27|2|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>ecromeximab_VL|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQTASSLPASLGDRVTISC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|5|YSSNLHS|IGKV1D-43|3|WYQQKPDGTVKLLIF|IGKV6-21/IGKV6D-21|4
>eculizumab_VL|GASENIYGALN|IGKV1-33/IGKV1D-33|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATNLAD|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>edrecolomab_VL|KASENVVTYVS|IGKV3-11|7|NIVMTQSPKSMSMSVGERVTLTC|IGKV1D-17|6|GASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPEQSPKLLIY|IGKV4-1|2
>efalizumab_VL|RASKTISKYLA|IGKV1-16/IGKV1-27|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SGSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>efungumab_VL|RASSGISRYLA|IGKV1-16/IGKV1-27|2|DVVMTQSPSFLSAFVGDRITITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|5|AASTLQT|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQAPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>eglatoprutug_VL|RASESVDIYGQSFMH|||DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|LASNLES|IGKV1-33/IGKV1D-33|2|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>eldelumab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>elezanumab_VL|TGTSSSVGDSIYVS|IGLV2-11/IGLV2-14/IGLV2-8|4|QSALTQPRSVSGSPGQSVTISC|IGLV2-11|0|DVTKRPS|IGLV2-11|1|WYQQHPGKAPKLMLY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|1
>elgemtumab_VL|RASQGISNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>elipovimab_VL|GEKSLGSRAVQ|IGLV3-12|6|SDISVAPGETARISC|||NNQDRPS|IGLV1-40|3|WYQHRAGQAPSLIIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|5
>elotuzumab_VL|KASQDVGIAVA|IGKV1D-13|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGKVPKLLIY|IGKV1-27|0
>elranatamab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|DASIRAT|IGKV3-11/IGKV3D-11|1|WYQQKPGQAPRLLMY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>elranatamab_VL_1|KSSQSLFNVRSRKNYLA|IGKV4-1|7|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIS|IGKV4-1|1
>eltrekibart_VL|RASQSISNNLH|IGKV1-16/IGKV1-27|3|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|YTSRSVS|IGKV6-21/IGKV6D-21|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>eluvixtamab_VL|KSSQSVLDSSTNKNSLA|IGKV4-1|3|DIVMTQSPDSLTVSLGERTTINC|IGKV4-1|2|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLLS|IGKV4-1|2
>eluvixtamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>emactuzumab_VL|RASEDVNTYVS|IGKV3-11|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>emapalumab_VL|TRSSGSIASNYVQ|IGLV6-57|0|NFMLTQPHSVSESPGKTVTISC|IGLV6-57|0|EDNQRPS|IGLV6-57|0|WYQQRPGSSPTTVIY|IGLV6-57|0
>emerfetamab_VL|KSSQSVLDSSTNKNSLA|IGKV4-1|3|DIVMTQSPDSLTVSLGERTTINC|IGKV4-1|2|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLLS|IGKV4-1|2
>emerfetamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>emibetuzumab_VL|SVSSSVSSIYLH|IGKV3-20|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|STSNLAS|IGLV7-43|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>emicizumab_VL|KASRNIERQLA|IGKV1-12/IGKV1D-12/IGKV1D-16|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|QASRKES|IGKV1-NL1|2|WYQQKPGQAPELLIY|IGKV1D-8|1
>emicizumab_VL_1|KASRNIERQLA|IGKV1-12/IGKV1D-12/IGKV1D-16|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|QASRKES|IGKV1-NL1|2|WYQQKPGQAPELLIY|IGKV1D-8|1
>emirodatamab_VL|RASQGIRNDLG|IGKV1-17/IGKV1-6|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGKAPKRLIY|IGKV1-17|0
>emirodatamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>empasiprubart_VL|RASKSVRTSGYNYMH|||DNVLTQSPDSLAVSLGERATISC|IGKV4-1|3|LASNLKS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQPPKLLIY|IGKV4-1|0
>enapotamab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>enavatuzumab_VL|RASQSVSTSSYSYMH|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGKAPKLLIK|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>encelimab_VL|RSSQSLVHSDSNTYLH|IGKV2-24|2|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|LVSNRFS|IGKV2D-26/IGKV2D-29|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>enfortumab_VL|RASQGISGWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGKAPKFLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>englumafusp_VL|KSSQSLETSTGTTYLN|IGKV2-30/IGKV2D-30|5|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|RVSKRFS|IGKV2D-26/IGKV2D-29|2|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>enibarcimab_VL|RSSQSIVYSNGNTYLE|IGKV2-30/IGKV2D-30|3|DVVLTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|1|RVSNRFS|IGKV2D-26/IGKV2D-29|1|WYLQRPGQSPRLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>enlonstobart_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|TASNRAT|IGKV3-11/IGKV3D-11|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>enoblituzumab_VL|KASQNVDTNVA|IGKV3-15/IGKV3D-15|5|DIQLTQSPSFLSASVGDRVTITC|IGKV1-9|0|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGKAPKALIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>enokizumab_VL|KASQHVITHVT|IGKV3-11|7|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GTSYSYS|IGKV2-40/IGKV2D-40|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>enoticumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ensituximab_VL|SASSSISYMY|||QVVLTQSPVIMSASPGEKVTMTC|IGKV6-21/IGKV6D-21|9|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGTSPKRWIY|IGKV1-17|3
>enuzovimab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>epacmarstobart_VL|RASENIYSYLA|IGKV1-8/IGKV1-9|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|TAKTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>epcoritamab_VL|RSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSFSVSPGGTVTLTC|IGLV8-61|1|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQTPGQAFRGLIG|IGLV8-61|4
>epcoritamab_VL_1|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>epratuzumab_VL|KSSQSVLYSANHKNYLA|IGKV4-1|2|DIQLTQSPSSLSASVGDRVTMSC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|3|WASTRES|IGKV4-1|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>eptinezumab_VL|QASQSVYHNTYLA|IGLV1-51|9|QVLTQSPSSLSASVGDRVTINC|IGLV1-40|12|DASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKVPKQLIY|IGKV1-27|1
>eramkafusp_VL|RASSSVSYIH|||QIVLSQSPAILSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGSSPKPWIY|IGKV1-16|4
>erenumab_VL|SGSSSNIGNNYVS|IGLV1-51|0|QSVLTQPPSVSAAPGQKVTISC|IGLV1-51|0|DNNKRPS|IGLV1-51|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>erlizumab_VL|RASQDINNYLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSTLHS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ersodetug_VL|RSSLSLVYGDENTYLN|IGKV2-30/IGKV2D-30|3|DVVMTQSPLSLSVTLGQPASISC|IGKV2-30/IGKV2D-30|1|KVSDRDS|IGKV2-30|1|WFQQRPGQSPRRLLY|IGKV2-30/IGKV2D-30|1
>erzotabart_VL|RASQGIRSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>etaracizumab_VL|QASQSISNFLH|IGKV1-33/IGKV1D-33|3|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|YRSQSIS|IGKV6-21/IGKV6D-21|2|WYQQRPGQAPRLLIR|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|2
>etesevimab_VL|RASQSISRYLN|IGKV1-39/IGKV1D-39|1|DIVMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>etevritamab_VL|RSSQSLVHSDGNTYLS|IGKV2-24|0|DTVMTQTPLSSHVTLGQPASISC|IGKV2-24|2|RISRRFS|IGKV2-24|2|WLQQRPGQPPRLLIY|IGKV2-24|0
>etevritamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>etigilimab_VL|KASQDVSTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>etokimab_VL|KASQDVGTAVA|IGKV1D-13|6|DIQLTQSPSFLSASVGDRVTITC|IGKV1-9|0|WASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>etrolizumab_VL|RASESVDDLLH|IGKV3-11|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YASQSIS|IGKV6-21/IGKV6D-21|1|WYQQKPGKAPKLLIK|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>eurestobart_VL|SAFSSVNYMH|||QIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|TTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>evalstotug_VL|RASQYVGSSYLA|IGKV3-20|2|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|GAFSRAT|IGKV3-20|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>evinacumab_VL|RASQSIRSWLA|IGKV1-5|1|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASSLES|IGKV1-5/IGKV1D-13|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>evolocumab_VL|TGTSSDVGGYNSVS|IGLV2-11/IGLV2-14/IGLV2-8|1|ESALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|1|EVSNRPS|IGLV2-14/IGLV2-18|0|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>evunzekibart_VL|RASQSIGSTLN|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>exbivirumab_VL|GGNNIGTKNVH|IGLV3-9|1|SYVLTQPPSVSVAPGKTARISC|IGLV3-21|1|ADSDRPS|IGLV3-21|1|WYQQKPGQAPVLVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>exidavnemab_VL|RSSQTIVHNNGNTYLE|IGKV2-24|5|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>exlinkibart_VL|RASQDIRSNLN|IGKV1-39/IGKV1D-39|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLHS|IGKV1-NL1|3|WYQQKPGGAVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>ezabenlimab_VL|RASENIDVSGISFMN|||EIVLTQSPATLSLSPGERATMSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|VASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQQKPGQAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>falbikitug_VL|RSSQSLLDSDGHTYLN|IGKV2-30/IGKV2D-30|3|DIVMTQTPLSSPVTLGQPASISC|IGKV2-24|0|SVSNLES|IGKV1-33/IGKV1D-33|3|WLQQRPGQPPRLLIY|IGKV2-24|0
>fanastomig_VL|RASQEISGYLS|IGKV1-16/IGKV1-27|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASALDS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WLQQKPGGAIKRLIY|IGKV1-17|3
>fanastomig_VL_1|KASDHINNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATSLET|IGKV1-33/IGKV1D-33|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>faricimab_VL|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|FTSSLHS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>faricimab_VL_1|GGNNIGSKSVH|IGLV3-21|0|SYVLTQPPSVSVAPGQTARITC|IGLV3-21|1|DDSDRPS|IGLV3-21|1|WYQQKPGQAPVLVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>farletuzumab_VL|SVSSSISSNNLH|IGKV3-20|7|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|GTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGKAPKPWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>fasinumab_VL|RASQAIRNDLG|IGKV1-17/IGKV1-6|1|DIQMTQSPSSLSASAGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AAFNLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WYQQKPGKAPKRLIY|IGKV1-17|0
>favezelimab_VL|KASQSLDYEGDSDMN|||DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|GASNLES|IGKV1-33/IGKV1D-33|2|WYLQKPGQPPQLLIY|IGKV2D-29|0
>fazpilodemab_VL|RASESVESYGNRYMT|||DIVLTQSPDSLAVSLGERATINC|IGKV4-1|1|RAANLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQPPKLLIY|IGKV4-1|0
>fazpilodemab_VL_1|RASQDVSTAVA|IGKV1D-13|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>feladilimab_VL|SASSSVSYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>felzartamab_VL|SGDNLRHYYVY|IGLV3-10|5|DIELTQPPSVSVAPGQTARISC|IGLV3-10|4|GDSKRPS|IGLV3-1|1|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>fepixnebart_VL|RSSQSIVHSTGNTYLE|IGKV2-24|3|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|KVSNRFS|IGKV2-24|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>fezakinumab_VL|TGSSSNIGAGYGVH|IGLV1-40|1|QAVLTQPPSVSGAPGQRVTISC|IGLV1-40|1|GDSNRPS|IGLV1-40|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>fianlimab_VL|RASQRISTYLA|IGKV1-16/IGKV1-27|2|EIVLTQSPATLSLSPGERTTLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|DASKRAT|IGKV3-11/IGKV3D-11|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ficlatuzumab_VL|KASENVVSYVS|IGKV3-11|6|DIVMTQSPDSLAMSLGERVTLNC|IGKV4-1|3|GASNRES|IGKV4-1|2|WYQQKPGQSPKLLIY|IGKV4-1|1
>fidasimtamab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>fidasimtamab_VL_1|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>figitumumab_VL|RASQGIRNDLG|IGKV1-17/IGKV1-6|0|DIQMTQFPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASRLHR|IGKV1-NL1|2|WYQQKPGKAPKRLIY|IGKV1-17|0
>finotonlimab_VL|RASESVDSYGNSFMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQPPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>firastotug_VL|RASQSVRGRFLA|IGKV3-20|4|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>firivumab_VL|RASENIWNNLA|IGKV1-16/IGKV1-27|4|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|GASTGAT|IGKV3-15/IGKV3D-15/IGKV3D-7|1|WYQQKPGQAPRLLIS|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>fiztasovimab_VL|SGSLSNIGTNYVY|IGLV1-47|2|QSVLTQPPSASGTPGQRVSISC|IGLV1-44/IGLV1-47|1|KNNQRPS|IGLV1-44|1|WYQQLPGTAPKLLIF|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|1
>flanvotumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>fletikumab_VL|RASQGISSALA|IGKV1D-13|0|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|DASSLES|IGKV1-5/IGKV1D-13|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>flotetuzumab_VL|KSSQSLLNSGNQKNYLT|IGKV4-1|5|DFVMTQSPDSLAVSLGERVTMSC|IGKV4-1|4|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>flotetuzumab_VL_1|RSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>fontolizumab_VL|KASENVDTYVS|IGKV3-11|7|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|GASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>foralumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>foravirumab_VL|RASQGIRNDLG|IGKV1-17/IGKV1-6|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>forimtamig_VL|RASQSVSISGINLMN|||EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|HASILAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQQPKLLIY|IGKV4-1|1
>forimtamig_VL_1|GSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQEKPGQAFRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|5
>fremanezumab_VL|KASKRVTTYVS|IGKV3-11|7|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|GASNRYL|IGKV3-11/IGKV3D-11|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>freneslerbart_VL|RASQGISNYLA|IGKV1-16/IGKV1-27|0|DIQVTQSPSPLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGRVPQLLIY|IGKV1-27|2
>fresolimumab_VL|RASQSLGSSYLA|IGKV3-20|2|ETVLTQSPGTLSLSPGERATLSC|IGKV3-20|1|GASSRAP|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>frexalimab_VL|KASSNLGHAVA|IGKV1D-13|7|DIVMTQSPSFLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|SASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPGKSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>frovocimab_VL|RSSKSLLHRNGITYSY|IGKV2D-26|5|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|QLSNLAS|IGKV2-28/IGKV2D-28|3|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>frunevetmab_VL|RASEDIYNALA|IGKV1-16/IGKV1-27|4|DIEMTQSPLSLSVTPGESVSISC|IGKV2-28/IGKV2D-28|4|NTDTLHT|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|5|WYLQKPGRSPRLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>fulranumab_VL|RASQGISSALA|IGKV1D-13|0|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|DASSLES|IGKV1-5/IGKV1D-13|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>futuximab_VL|RTSQDIGNYLN|IGKV1-33/IGKV1D-33|3|DIQMTQTTSSLSASLGDRVTISC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|YTSRLHS|IGKV1-NL1|3|WYQQKPDGTVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>galcanezumab_VL|RASKDISKYLN|IGKV1-33/IGKV1D-33|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSGYHS|IGLV7-43|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>galegenimab_VL|RASSSVEFIH|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKPLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>galiximab_VL|TGSTSNIGGYDLH|IGLV1-36|7|ESALTQPPSVSGAPGQKVTISC|IGLV1-40|3|DINKRPS|IGLV1-51|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>galvokimig1_VL|RADESVRTLMH|IGKV3-11|7|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|LVSNSEI|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>galvokimig1_VL_1|QSSPSVWSNFLS|IGKV3D-7|6|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|EASKLTS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>galvokimig2_VL|KASQNINENLD|IGKV1-12/IGKV1D-12/IGKV1D-16|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTDILQT|IGKV1D-43|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>gancotamab_VL|TGSSSNIGAGYGVH|IGLV1-40|1|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|GNTNRPS|IGLV1-40|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>ganitumab_VL|RSSQSLLHSNGYNYLD|IGKV2-28/IGKV2D-28|0|DVVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|1|LGSNRAS|IGKV2-28/IGKV2D-28|0|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>gantenerumab_VL|RASQSVSSSYLA|IGKV3-20|0|DIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>garadacimab_VL|SGSSSNIGRNYVY|IGLV1-47|1|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|SNNQRPS|IGLV1-44|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>garetosmab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>garivulimab_VL|KASQDVGIVVA|IGKV3-11|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASIRHT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>gatipotuzumab_VL|RSSKSLLHSNGITYFF|IGKV2-28/IGKV2D-28|5|DIVMTQSPLSNPVTPGEPASISC|IGKV2-28/IGKV2D-28|1|QMSNLAS|IGKV2-28/IGKV2D-28|3|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>gatralimab_VL|KSSQSLLYSNGKTYLN|IGKV2D-29|3|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|LVSKLDS|IGKV2-30|3|WVLQKPGQSPQRLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>gedivumab_VL|RASQVISHNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|3|EIVLTQSPATLSVSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|GASTRAS|IGKV3-15/IGKV3D-15/IGKV3D-7|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>gemtuzumab_VL|RASESLDNYGIRFLT|||DIQLTQSPSTLSASVGDRVTITC|IGKV1-5|1|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGKAPKLLMY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>geptanolimab_VL|RASESVDNYGYSFMN|||DIVLTQSPASLAVSPGQRATITC|IGKV4-1|5|RASNLES|IGKV1-33/IGKV1D-33|2|WFQQKPGQPPKLLIY|IGKV4-1|1
>gevokizumab_VL|RASQDISNYLS|IGKV1-16/IGKV1-27|2|DIQMTQSTSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|YTSKLHS|IGKV1D-43|3|WYQQKPGKAVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>giloralimab_VL|RSSQSLENTNGNTFLN|IGKV2-30/IGKV2D-30|5|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|RVSNRFS|IGKV2D-26/IGKV2D-29|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>gilvetmab_VL|HASQNINVWLS|IGKV1-12/IGKV1D-12/IGKV1D-16|5|DIVMTQTPLSLSVSLGEPASISC|IGKV2-40/IGKV2D-40|3|KASHLHT|IGKV1-33/IGKV1D-33|3|WYRQKPGQIPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>gimsilumab_VL|RASQSVSTNLA|IGKV3-15/IGKV3D-15|1|EIVLTQSPVTLSVSPGERVTLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|3|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKLGQGPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|2
>ginisortamab_VL|KSSQSVLYSSNNKNYLA|IGKV4-1|0|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>girentuximab_VL|KASQNVVSAVA|IGKV1D-13|5|DIVMTQSQRFMSTTVGDRVSITC|IGKV1-12/IGKV1D-12|8|SASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPGQSPKLLIY|IGKV4-1|1
>givastomig_VL|KSSQSLLNAGNQKNYLT|IGKV4-1|6|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|RASSRES|IGKV1-5/IGKV1D-13|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>givastomig_VL_1|SGSSSNIGNNYVT|IGLV1-51|1|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|ADSHRPS|IGLV3-1|2|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>glembatumumab_VL|RASQSVDNNLV|IGKV3-15/IGKV3D-15|3|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>glenzocimab_VL|RSSQSLENSNGNTYLN|IGKV2-30/IGKV2D-30|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|RVSNRFS|IGKV2D-26/IGKV2D-29|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>glofitamab_VL|GSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQEKPGQAFRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|5
>glofitamab_VL_1|RSSKSLLHSNGITYLY|IGKV2D-26|3|DIVMTQTPLSLPVTPGEPASISC|IGKV2-40/IGKV2D-40|0|QMSNLVS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>golimumab_VL|RASQSVYSYLA|IGKV3-11|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>golocdacimab_VL|TGSSSNIGAGYDVH|IGLV1-40|0|QSVVTQPPSVSGAPGQRVTISC|IGLV1-40|1|GNSNRPS|IGLV1-40|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>gorivitug_VL|RAGQSISSFLN|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>gosuranemab_VL|KSSQSIVHSNGNTYLE|IGKV2-24|4|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLVY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>gotistobart_VL|RASENIYSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AATNLQD|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKQGKAPKLLLY|IGKV1-NL1|1
>gremubamab_VL|RASQGIRNDLG|IGKV1-17/IGKV1-6|0|AIQMTQSPSSLSASVGDRVTITC|IGKV1-6|0|SASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>gremubamab_VL_1|RASQSIRSHLN|IGKV1-39/IGKV1D-39|2|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|GASNLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>gresonitamab_VL|RASQGVNNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|3|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|TASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>gresonitamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>grisnilimab_VL|RSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQESALTTSPGETVTLTC|IGLV7-46|4|GTNNRAP|IGLV3-19|3|WVQEKPDHLFTGLIG|IGKV6-21/IGKV6D-21|8
>gruticibart_VL|KASQDVSTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|LTSYRNT|IGKV2-28/IGKV2D-28|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>gulgafafusp_VL|RASQNINNLLA|IGKV1-16/IGKV1-27|3|AIQMTQSPSSVSASIGDRVTITC|IGKV1-12/IGKV1D-12|2|TASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>gumokimab_VL|RSSQSLVHSNGNTYLH|IGKV2-24|2|DVVMTQTPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|1|KVSNRFS|IGKV2-24|1|WYLQKPGQSPRLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>guselkumab_VL|TGSSSNIGSGYDVH|IGLV1-40|1|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|GNSKRPS|IGLV1-40|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>ianalumab_VL|RASQFISSSYLS|IGKV3D-7|2|DIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|GSSSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ibalizumab_VL|KSSQSLLYSTNQKNYLA|IGKV4-1|3|DIVMTQSPDSLAVSLGERVTMNC|IGKV4-1|2|WASTRES|IGKV4-1|0|WYQQKPGQSPKLLIY|IGKV4-1|1
>ibentatug_VL|RSSKSLLHSQGITYLY|IGKV2D-26|3|DIVMTQSALSNPVTLGQSASISC|IGKV2-24|4|QMSNRAS|IGKV2-28/IGKV2D-28|2|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>ibritumomab_VL|RASSSVSYMH|||QIVLSQSPAILSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|APSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGSSPKPWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>icrucumab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>idactamab_VL|RASQSIRSWLA|IGKV1-5|1|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASILKI|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>idarucizumab_VL|KSSQSLLYTDGKTYLY|IGKV2D-29|2|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|LVSKLDS|IGKV2-30|3|WFLQRPGQSPRRLIY|IGKV2-30/IGKV2D-30|1
>ieramilimab_VL|SSSQDISNYLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSTLHL|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>ifabotuzumab_VL|RASQGIISYLA|IGKV1-8/IGKV1-9|1|DIQMTQSPSFLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKRLIY|IGKV1-17|1
>ifinatamab_VL|RASSRLIYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQAPRPLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>iladatuzumab_VL|KASQSVDYEGDSFLN|||DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASNLES|IGKV1-NL1|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>iluzanebart_VL|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WFQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>imalumab_VL|RSSQRIMTYLN|IGKV1-39/IGKV1D-39|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|VASHSQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>imaprelimab_VL|KASQNIYNSLA|IGKV1-NL1|3|DIQMTQSPSSLSASVGDRVTINC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|NANSLQT|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>imgatuzumab_VL|RASQGINNYLN|IGKV1-16/IGKV1-27|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NTNNLQT|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKRLIY|IGKV1-17|0
>imsidolimab_VL|RSSKSLLHRNAITYFY|IGKV2D-26|6|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|QMSNLAS|IGKV2-28/IGKV2D-28|3|WYLHKPGQPPQLLIY|IGKV2D-29|1
>imvotamab_VL|SASSSVSYMN|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGKAPKRLIY|IGKV1-17|0
>imvotamab_VL_1|RSSQSLVYSDGNTYLS|IGKV2-24|1|DIVMTQTPLSSPVTLGQPASISC|IGKV2-24|0|KISNRFS|IGKV2-24|0|WLQQRPGQPPRLLIY|IGKV2-24|0
>inclacumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>indatuximab_VL|SASQGINNYLN|IGKV1-16/IGKV1-27|3|DIQMTQSTSSLSASLGDRVTISC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|3|YTSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPDGTVELLIY|IGKV1D-8|4
>indusatumab_VL|RASQSVSRNLA|IGKV3-15/IGKV3D-15|1|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>inebilizumab_VL|RASESVDTFGISFMN|||EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|EASNQGS|IGKV2D-26/IGKV2D-29|3|WFQQKPDQSPKLLIH|IGKV6-21/IGKV6D-21|2
>inezetamab_VL|TGTSSDVGNYNLVS|IGLV2-23|1|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|EVNQRPS|IGLV6-57|1|WYQQHPGKAPKLMIF|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|1
>inezetamab_VL_1|RASQDISRWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|2|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASRLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>infliximab_VL|RASQFVGSSIH|IGKV6-21/IGKV6D-21|3|DILLTQSPAILSVSPGERVSFSC|IGKV3-11/IGKV3D-11/IGKV3D-20|7|YASESMS|IGKV6-21/IGKV6D-21|2|WYQQRTNGSPRLLIK|IGKV6-21/IGKV6D-21|5
>inotuzumab_VL|RSSQSLANSYGNTFLS|IGKV2-24|4|DVQVTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|GISNRFS|IGKV2-24|1|WYLHKPGKAPQLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>intetumumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>iparomlimab_VL|KSSQSLFNSGNQKNYLA|IGKV4-1|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASTRDS|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGKVPKLLIY|IGKV1-27|0
>ipilimumab_VL|RASQSVGSSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GAFSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>iratumumab_VL|RASQGISSWLT|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPTSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>isatuximab_VL|KASQDVSTVVA|IGKV3-11|5|DIVMTQSHLSMSTSLGDPVSITC|IGKV1-12/IGKV1D-12|8|SASYRYI|IGKV2-40/IGKV2D-40|4|WYQQKPGQSPRRLIY|IGKV2-30/IGKV2D-30|2
>iscalimab_VL|RSSQSLLYSNGYNYLD|IGKV2-28/IGKV2D-28|1|DIVMTQSPLSLTVTPGEPASISC|IGKV2-28/IGKV2D-28|1|LGSNRAS|IGKV2-28/IGKV2D-28|0|WYLQKPGQSPQVLIS|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>ispectamab_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>istiratumab_VL|RASQGISSYLA|IGKV1-8/IGKV1-9|0|DIQMTQSPSSLSASLGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AKSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>istiratumab_VL_1|QGDSLRSYYAS|IGLV3-19|0|SYELTQDPAVSVALGQTVRITC|IGLV3-19|1|GKNNRPS|IGLV3-19|0|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>itepekimab_VL|RASQGIFSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>itolizumab_VL|KASRDIRSYLT|IGKV1-33/IGKV1D-33|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YATSLAD|IGKV1D-43|3|WYQQKPGKAPKTLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>ivicentamab_VL|QASQNIDSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DVVMTQSPSTLSASVGDRVTITC|IGKV1-5|2|YASNLPF|IGKV1-33/IGKV1D-33|3|WYQQKPGKAPKFLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>ivicentamab_VL_1|QASQNIIDYLA|IGKV1-16/IGKV1-27|4|AYDMTQSPSTLSASVGDRVTITC|IGKV1-5|3|KASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>ivonescimab_VL|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|FTSSLHS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>ivonescimab_VL_1|RASQDINTYLS|IGKV1-16/IGKV1-27|4|DIQMTQSPSSMSASVGDRVTFTC|IGKV1-12/IGKV1D-12|2|RANRLVS|IGKV1-NL1|3|WFQQKPGKSPKTLIY|IGKV1-16|2
>ivuxolimab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>ixekizumab_VL|RSSRSLVHSRGNTYLH|IGKV2-24|3|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|KVSNRFI|IGKV2-24|2|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>izalontamab_VL|RASQSIGTNIH|IGKV6-21/IGKV6D-21|3|DILLTQSPVILSVSPGERVSFSC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|YASESIS|IGKV6-21/IGKV6D-21|2|WYQQRTNGSPRLLIK|IGKV6-21/IGKV6D-21|5
>izalontamab_VL_1|TGTSSDVGGYNFVS|IGLV2-11/IGLV2-14/IGLV2-8|1|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|DVSDRPS|IGLV2-11|1|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>izastobart_VL|SGSSSNIGSYYVS|IGLV1-47|2|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|RNNQRPS|IGLV1-47|0|WYQQLPGTAPKVLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|1
>izeltabart_VL|KASQSVDYSGDSYMN|||DIVMTQSPDSLAVSLGERATISC|IGKV4-1|1|AASDLES|IGKV1-NL1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>izenivetmab_VL|RASENIYSFLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|EIVMTQSPASLSLSQEEKVTITC|IGKV3D-7|7|NANTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGQAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>izuralimab_VL|RASQGISRLLA|IGKV1-12/IGKV1D-12/IGKV1D-16|2|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|VASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>izuralimab_VL_1|RASQSVGNDVA|IGKV3-11|4|EIVLTQSPATLSASPGERVTLTC|IGKV3-11/IGKV3D-11/IGKV3D-20|3|YASHRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGQAPRLLIN|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>labetuzumab_VL|KASQDVGTSVA|IGKV1-NL1|6|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|WTSTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>lacnotuzumab_VL|QASQSIGTSIH|IGKV6-21/IGKV6D-21|3|DIVLTQSPAFLSVTPGEKVTFTC|IGKV6-21/IGKV6D-21|5|YASESIS|IGKV6-21/IGKV6D-21|2|WYQQKTDQAPKLLIK|IGKV6-21/IGKV6D-21|2
>lacutamab_VL|KASQDVSTAVA|IGKV1D-13|5|DIQMTQSPSFLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|WTSTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|3|WYQQKPGQPPKLLIY|IGKV4-1|0
>ladiratuzumab_VL|RSSQSLLHSSGNTYLE|IGKV2-24|3|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|KISTRFS|IGKV2-24|1|WYQQRPGQSPRPLIY|IGKV2-30/IGKV2D-30|2
>lafuvitug_VL|QANGYLN|||DIQMTQSPSSLSASVGDTVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|DGSKLER|IGKV1-33/IGKV1D-33|3|WYQQRRGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>lampalizumab_VL|ITSTDIDDDMN|IGKV5-2|3|DIQVTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|GGNTLRP|IGKV5-2|4|WYQQKPGKVPKLLIS|IGKV1-27|1
>lanadelumab_VL|RASQSISSWLA|IGKV1-5|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASTLES|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>lancastotug_VL|RSSQHVSTALA|IGKV1D-13|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASSRYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>landogrozumab_VL|RASSSVSSSYLH|IGKV3-20|2|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|STSNLVA|IGLV7-43|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>laprituximab_VL|RASQDINNYLA|IGKV1-16/IGKV1-27|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSTLHP|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQHKPGKGPKLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>larcaviximab_VL|RASENIYSYLA|IGKV1-8/IGKV1-9|3|DIQMTQSPASLSASVGETVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|3|NAKTLIE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKQGKSPQLLVY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>latikafusp_VL|SGDALPKKYAY|IGLV3-10|0|SYELTQPPSVSVSPGQTARITC|IGLV3-10|0|EDAKRPS|IGLV3-10|1|WYQQKPGQAPVLVIS|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>latozinemab_VL|RSSQSLLRSTGYNYLD|IGKV2-28/IGKV2D-28|2|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|LGSNRAS|IGKV2-28/IGKV2D-28|0|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>lebrikizumab_VL|RASKSVDSYGNSFMH|||DIVMTQSPDSLSVSLGERATINC|IGKV4-1|1|LASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>lecanemab_VL|RSSQSIVHSNGNTYLE|IGKV2-24|3|DVVMTQSPLSLPVTPGAPASISC|IGKV2-28/IGKV2D-28|2|KVSNRFS|IGKV2-24|1|WYLQKPGQSPKLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>lemalesomab_VL|RSSQSIVHSNGNTYLE|IGKV2-24|3|DIQLTQTPLSLPVSLGDQASISC|IGKV2-24|6|KVSNRFS|IGKV2-24|1|WYLQKPGQSPNLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>lemzoparlimab_VL|KSSQSVLYAGNNRNYLA|IGKV4-1|3|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|QASTRAS|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGQPPKLLIN|IGKV4-1|1
>lenvervimab_VL|RASQGIYNSIA|IGKV1-NL1|2|DIVVTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|STSTLLS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGKAPKLLLY|IGKV1-NL1|0
>lenzilumab_VL|RASQSVGTNVA|IGKV3-15/IGKV3D-15|3|EIVLTQSPATLSVSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|STSSRAT|IGKV3-20|2|WYQQKPGQAPRVLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>lepunafusp_VL|RSSQSLVHSNGNTYLH|IGKV2-24|2|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>lerdelimumab_VL|QGDSLRSYYAS|IGLV3-19|0|SSELTQDPAVSVALGQTVRITC|IGLV3-19|0|GKNNRPS|IGLV3-19|0|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>leronlimab_VL|RSSQRLLSSYGHTYLH|IGKV2D-26|5|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|EVSNRFS|IGKV2D-26/IGKV2D-29|0|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>lesabelimab_VL|RASQSIPSFLN|IGKV1-39/IGKV1D-39|2|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>lesofavumab_VL|RSSQSLLRSNGYNYLD|IGKV2-28/IGKV2D-28|1|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|LGSNRAS|IGKV2-28/IGKV2D-28|0|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>letaplimab_VL|RASQGISRWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>levilimab_VL|KSSQSVLSASNTYLN|||DIQLTQSPSSVSVSVGERVTIDC|IGKV1-12/IGKV1D-12|4|YASTRES|IGKV4-1|1|WYQQKPGQAPQLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>lexatumumab_VL|QGDSLRSYYAS|IGLV3-19|0|SSELTQDPAVSVALGQTVRITC|IGLV3-19|0|GKNNRPS|IGLV3-19|0|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>libivirumab_VL|RSSQSLLHRSGNNYLD|IGKV2-28/IGKV2D-28|3|DIVMTQSPLSLSVTPGEPASISC|IGKV2-28/IGKV2D-28|1|VGSNRAS|IGKV2-28/IGKV2D-28|1|WYLQKPGHSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>licaminlimab_VL|QSSQSVYGNIWMA|IGLV1-36|9|EIVMTQSPSTLSASVGDRVIITC|IGKV1-5|3|QASKLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGRAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>lifastuzumab_VL|RSSETLVHSSGNTYLE|IGKV2-24|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|RVSNRFS|IGKV2D-26/IGKV2D-29|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ligelizumab_VL|RASQSIGTNIH|IGKV6-21/IGKV6D-21|3|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|YASESIS|IGKV6-21/IGKV6D-21|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ligufalimab_VL|RASEIVGTYVS|IGKV3-11|6|NIVMTQSPATMSMSPGERVTLSC|IGKV3-15/IGKV3D-15|4|GASNRYT|IGKV3-11/IGKV3D-11|2|WFQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>lilotomab_VL|KASQDVSTAVD|IGKV1-33/IGKV1D-33|6|DIVMTQSHKLLSTSVGDRVSITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|6|WASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGQSPKLLIN|IGKV4-1|2
>linavonkibart_VL|QASQDITNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>lintuzumab_VL|RASESVDNYGISFMN|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>linvoseltamab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>linvoseltamab_VL_1|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>lipustobart_VL|RASKGVSTSGYSYLH|||EIVLTQSPATLSLSPGERATISC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|LASYLES|IGKV1-5/IGKV1D-13|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>lirentelimab_VL|SATSSVSYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|STSNLAS|IGLV7-43|2|WFQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>lirilumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPVTLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>litifilimab_VL|KASQSVDYDGDSYMN|||DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASTLES|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>livmoniplimab_VL|QASQSISSYLA|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASRLKT|IGKV1-33/IGKV1D-33|3|WYQQKPGQAPKILIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>lixudebart_VL|KASQNVGGNVD|IGKV3-15/IGKV3D-15|6|DIQMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|2|GASNRYT|IGKV3-11/IGKV3D-11|2|WYQWKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>lodapolimab_VL|SGSSSNIGSNTVN|IGLV1-44|0|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|GNSNRPS|IGLV1-40|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>lodelcizumab_VL|RASQSVSYMH|||QIVLTQSPATLSVSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|2|GVFRRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>lokivetmab_VL|KASQSVSFAGTGLMH|||EIVMTQSPASLSLSQEEKVTITC|IGKV3D-7|7|RASNLEA|IGKV1-33/IGKV1D-33|2|WYQQKPGQAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>lomtegovimab_VL|RASQSIDNWLA|IGKV1-5|2|DIQMTQSPSTVSASVGDRVTITC|IGKV1-12/IGKV1D-12|1|KASSLES|IGKV1-5/IGKV1D-13|1|WYQEKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>lomvastomig_VL|KASESVDTSDNSFIH|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|RSSTLES|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGQSPKLLIY|IGKV4-1|1
>lomvastomig_VL_1|RASQSVDNYVA|IGKV3-11|3|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|YASNRYI|IGKV3-11/IGKV3D-11|3|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>loncastuximab_VL|SASSGVNYMH|||EIVLTQSPAIMSASPGERVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|6|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGTSPRRWIY|IGKV1-17|4
>lonigutamab_VL|RASQDISKYLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLQS|IGKV1D-43|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>lorigerlimab_VL|RASESVDNYGMSFMN|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGQPPKLLIH|IGKV4-1|2
>lorigerlimab_VL_1|RASQSVSSSFLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>lorukafusp_VL|RSSQSLVHRNGNTYLH|IGKV2-24|3|DVVMTQTPLSLPVTPGEPASISC|IGKV2-40/IGKV2D-40|1|KVSNRFS|IGKV2-24|1|WYLQKPGQSPKLLIH|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>lorvotuzumab_VL|RSSQIIIHSDGNTYLE|IGKV2-24|4|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|KVSNRFS|IGKV2-24|1|WFQQRPGQSPRRLIY|IGKV2-30/IGKV2D-30|0
>losatuxizumab_VL|HSSQDINSNIG|IGKV1-12/IGKV1D-12/IGKV1D-16|7|DIQMTQSPSSMSVSVGDRVTITC|IGKV1-12/IGKV1D-12|2|HGTNLDD|IGKV1-33/IGKV1D-33|5|WLQQKPGKSFKGLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>lucatumumab_VL|RSSQSLLYSNGYNYLD|IGKV2-28/IGKV2D-28|1|DIVMTQSPLSLTVTPGEPASISC|IGKV2-28/IGKV2D-28|1|LGSNRAS|IGKV2-28/IGKV2D-28|0|WYLQKPGQSPQVLIS|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>lulizumab_VL|RASRPIWPFLE|IGKV1-12/IGKV1D-12/IGKV1D-16|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|FTSRLRH|IGKV1-NL1|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>lumiliximab_VL|RASQDIRYYLN|IGKV1-33/IGKV1D-33|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|VASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>lumretuzumab_VL|KSSQSVLNSGNQKNYLT|IGKV4-1|4|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>lumrotatug_VL|RASEDIYNRLV|IGKV1-16/IGKV1-27|5|EIVMTQSPPTLSLSPGERVTLSC|IGKV3D-7|2|GVTSLET|IGKV1-33/IGKV1D-33|4|WYQQKPGQAPRLLIS|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>lunaxafusp_VL|KASQDVYNAVA|IGKV1-16/IGKV1-27|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASSRYT|IGKV3-20|2|WYQQKPGQSPKLLIY|IGKV4-1|1
>lupartumab_VL|TGSSSNIGAGYVVH|IGLV1-40|1|ESVLTQPPSVSGAPGQRVTISC|IGLV1-40|1|DNNKRPS|IGLV1-51|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>lusvertikimab_VL|RTSEDIYQGLA|IGKV1-12/IGKV1D-12/IGKV1D-16|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SANTLHI|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGKAPKLLLY|IGKV1-NL1|0
>lutikizumab_VL|RASGNIHNYLT|IGKV1-16/IGKV1-27|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NAKTLAD|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQTPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>lutikizumab_VL_1|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|EASNLET|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>luvagrobart_VL|RASESISSNLN|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRFHS|IGLV7-43|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>luveltamab_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>maftivimab_VL|RASQSISSFLN|IGKV1-39/IGKV1D-39|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>magrolimab_VL|RSSQSIVYSNGNTYLG|IGKV2-30/IGKV2D-30|3|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>manelimab_VL|GLSSGTVTAINYPG|IGLV8-61|6|QTVVTQEPSLSVSPGGTVTLTC|IGLV7-43|1|NTNTRHS|IGLV8-61|2|WYQQTPGQAPRTLIY|IGLV8-61|0
>manfidokimab_VL|RASQDVTTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>margetuximab_VL|KASQDVNTAVA|IGKV1D-13|6|DIVMTQSHKFMSTSVGDRVSITC|IGKV1-12/IGKV1D-12|7|SASFRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGHSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>maridebart_VL|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GAATRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>marstacimab_VL|TGSSSNIGAGYDVH|IGLV1-40|0|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|GNSNRPS|IGLV1-40|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>masavibart_VL|TGTSSDVGGYNYVS|IGLV2-11/IGLV2-14/IGLV2-8|0|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|DVSKRPS|IGLV2-11|0|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>matuzumab_VL|SASSSVTYMY|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DTSNLAS|IGLV7-46|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>mavrilimumab_VL|TGSGSNIGAPYDVS|IGLV1-40|3|QSVLTQPPSVSGAPGQRVTISC|IGLV1-40|0|HNNKRPS|IGLV1-51|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>mazorelvimab_VL|KSTKSLLNSDGFTYLD|IGKV2D-29|5|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|LVSNRFS|IGKV2D-26/IGKV2D-29|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>mecbotamab_VL|KASQDVVSAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WQDTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>melredableukin_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>melrilimab_VL|RASQSVDDDLA|IGKV3-11|3|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>mepolizumab_VL|KSSQSLLNSGNQKNYLA|IGKV4-1|4|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|GASTRES|IGKV4-1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>metelimumab_VL|RASQGIGDDLG|IGKV1-17/IGKV1-6|2|EIVLTQSPSSLSASVGDRVTITC|IGKV1D-13|2|GTSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPILLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>mevonlerbart_VL|RASQSISSWLA|IGKV1-5|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASSLES|IGKV1-5/IGKV1D-13|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>mezagitamab_VL|SGSSSNIGDNYVS|IGLV1-51|1|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|RDSQRPS|IGLV3-9|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>mibavademab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>milatuzumab_VL|RSSQSLVHRNGNTYLH|IGKV2-24|3|DIQLTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|3|TVSNRFS|IGKV2D-26/IGKV2D-29|1|WFQQRPGQSPRLLIY|IGKV2-30/IGKV2D-30|1
>mipasetamab_VL|SASSSVSSGNFH|IGKV3-20|6|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|RTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGLAPRLLIY|IGKV3D-20|0
>miptenalimab_VL|KASQDVSTAVA|IGKV1D-13|5|DIQMTQSPSFLSASVGDRVSITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>mirikizumab_VL|KASDHILKFLT|IGKV1-12/IGKV1D-12/IGKV1D-16|7|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATSLET|IGKV1-33/IGKV1D-33|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>miromavimab_VL|KASQDVSTAVA|IGKV1D-13|5|DIVMTQSHKFMSTSVGDRVSITC|IGKV1-12/IGKV1D-12|7|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGQSPKLLIY|IGKV4-1|1
>mirvetuximab_VL|KASQSVSFAGTSLMH|||DIVLTQSPLSLAVSLGQPAIISC|IGKV2-30/IGKV2D-30|5|RASNLEA|IGKV1-33/IGKV1D-33|2|WYHQKPGQQPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|2
>mirzotamab_VL|KASQNVGFNVA|IGKV3-15/IGKV3D-15|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGKSPKALIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>mitazalimab_VL|TGSSSNIGAGYNVY|IGLV1-40|2|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|GNINRPS|IGLV1-40|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>modakafusp_VL|KASQNVDSDVD|IGKV5-2|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|KASNDYT|IGKV1-33/IGKV1D-33|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>modotuximab_VL|RSSKSLLHSNGITYLY|IGKV2D-26|3|DIVMTQAAFSNPVTLGTSASISC|IGKV2-24|6|QMSNLAS|IGKV2-28/IGKV2D-28|3|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>mogamulizumab_VL|RSSRNIVHINGDTYLE|IGKV2-24|7|DVLMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|2|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>monalizumab_VL|RASENIYSYLA|IGKV1-8/IGKV1-9|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NAKTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>mosunetuzumab_VL|KSSQSLLNSRTRKNYLA|IGKV4-1|5|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>mosunetuzumab_VL_1|RASSSVSYMH|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|APSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKPLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>motavizumab_VL|SASSRVGYMH|||DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>moxetumomab_VL|RASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQTTSSLSASLGDRVTISC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|YTSILHS|IGKV1D-43|3|WYQQKPDGTVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>mupadolimab_VL|RASKNVSTSGYSYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|LASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>murlentamab_VL|RASSSVRYIA|||DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|PTSSLKS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLTY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>muromonab_VL|SASSSVSYMN|||QIVLTQSPAIMSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKSGTSPKRWIY|IGKV1-17|4
>muzastotug_VL|RASQSVRGRFLA|IGKV3-20|4|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>nadecnemab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>nadunolimab_VL|QASQGINNYLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSGLHA|IGKV1D-43|4|WYQQKPGKAPKLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>namilumab_VL|RASQNIRNILN|IGKV1-17/IGKV1-6|3|DIQMTQSPSSVSASVGDRVTIAC|IGKV1-12/IGKV1D-12|1|AASNLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQRPGKAPQLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>naptumomab_VL|KASQSVSNDVA|IGKV3-11|4|SIVMTQTPTSLLVSAGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|7|YTSSRYA|IGKV1D-43|4|WYQQKPGQSPKLLIS|IGKV4-1|2
>naratuximab_VL|RASENIRSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQMTQSPSSLSVSVGERVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|VATNLAD|IGKV1-33/IGKV1D-33|4|WYQQKPGKSPKLLVN|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>narlumosbart_VL|RASQSVRGRYLA|IGKV3-20|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>narnatumab_VL|RASQSVSRYLA|IGKV3-11|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>narsoplimab_VL|SGEKLGDKYAY|IGLV3-1|2|QPVLTQPPSLSVSPGQTASITC|IGLV3-1|4|QDKQRPS|IGLV3-1|2|WYQQKPGQSPVLVMY|IGLV3-1|1
>natalizumab_VL|KTSQDINKYMA|IGKV5-2|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSALQP|IGKV1D-43|3|WYQQTPGKAPRLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>navicixizumab_VL|RASESVDNYGISFMK|||DIVMTQSPDSLAVSLGERATISC|IGKV4-1|1|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGQPPKLLIY|IGKV4-1|1
>navicixizumab_VL_1|RASESVDNYGISFMK|||DIVMTQSPDSLAVSLGERATISC|IGKV4-1|1|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGQPPKLLIY|IGKV4-1|1
>navivumab_VL|RASHRVGSTYIA|IGKV3-20|5|EVVLTQSPGTLALPPGERATLSC|IGKV3-20|3|GASNRAT|IGKV3-11/IGKV3D-11|1|WYQQKSGQAPRRLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|2
>naxitamab_VL|KASQSVSNDVT|IGKV3-11|5|EIVMTQTPATLSVSAGERVTITC|IGKV3-15/IGKV3D-15|5|SASNRYS|IGLV3-12|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>nebratamig1_VL|QASQNIRTYLS|IGKV1-33/IGKV1D-33|4|DVVMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|2|AAANLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>nebratamig1_VL_1|QASEDIYSFLA|IGKV1-12/IGKV1D-12/IGKV1D-16|5|AYDMTQSPSSVSASVGDRVTIKC|IGKV1-12/IGKV1D-12|4|SASSLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WYQQKPGKAPKLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>nebratamig2_VL|QSSQSVYNNNDLA|IGLV1-36|9|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKVPKLLIY|IGKV1-27|0
>nebratamig2_VL_1|QASESISSWLA|IGKV1-5|2|DVVMTQSPSTLSASVGDRVTINC|IGKV1-5|3|EASKLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>necitumumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVMTQSPATLSLSPGERATLSC|IGKV3D-7|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>negalstobart_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>nelistotug_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>nelmastobart_VL|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSSLHS|IGKV1D-43|2|WYQQKPGKAVKLLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>nemolizumab_VL|QASEDIYSFVA|IGKV1-12/IGKV1D-12/IGKV1D-16|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NAQTEAQ|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>nepuvibart_VL|QASQDITNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASNLET|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>nesvacumab_VL|RASQSVSSTYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>netakimab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|DASSRAT|IGKV3D-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>nezastomig_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>nezastomig_VL_1|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>nezutatug_VL|KASQIVGSNVA|IGKV3-15/IGKV3D-15|4|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|SASYLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPEPLIY|IGKV1D-8|1
>nimacimab_VL|RASQSVSSSYLH|IGKV3-20|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|STSNLAS|IGLV7-43|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>nimotuzumab_VL|RSSQNIVHSNGNTYLD|IGKV2-24|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|KVSNRFS|IGKV2-24|1|WYQQTPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>nipocalimab_VL|TGTGSDVGSYNLVS|IGLV2-23|1|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|GDSERPS|IGLV3-16/IGLV3-25/IGLV3-27|1|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>nirsevimab_VL|QASQDIVNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSAAVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|VASNLET|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>nisevokitug_VL|GANDIGSKSVH|IGLV3-21|2|SYELTQPPSVSVAPGQTARITC|IGLV3-10|1|EDIIRPS|IGLV3-10|2|WYQQKAGQAPVLVVS|IGLV3-10|3
>nivatrotamab_VL|KASQSVSNDVT|IGKV3-11|5|EIVMTQTPATLSVSAGERVTITC|IGKV3-15/IGKV3D-15|5|SASNRYS|IGLV3-12|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>nivatrotamab_VL_1|SASSSVSYMN|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQTPGKAPKRWIY|IGKV1-17|2
>nivolumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>nofazinlimab_VL|RSSQSLLDSDGGTYLY|IGKV2D-26|2|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|LVSTLGS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WFQQRPGQSPRRLIY|IGKV2-30/IGKV2D-30|0
>nolavetbart_VL|KSSQSVTNDLT|IGKV1-17/IGKV1-6|6|RIVMTQSPGSLAGSVGESVSINC|IGKV4-1|7|YASQRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGEAPKVLIT|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>nurulimab_VL|RASQSVGSSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GAFSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>oberotatug_VL|RASQSISDYLS|IGKV1-39/IGKV1D-39|2|DVQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASNLKT|IGKV1-33/IGKV1D-33|2|WYQQRPGKAPNLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>obertamig_VL|TGTSSNIGTYKFVS|IGLV2-11/IGLV2-14/IGLV2-8|5|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|EVSKRPS|IGLV2-8|0|WYQQHPDKAPKVLLY|IGKV1-NL1|3
>obertamig_VL_1|KSSQSVLHSSNNKNYLT|IGKV4-1|2|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WFQQKPGQPPKLLIY|IGKV4-1|1
>obexelimab_VL|RSSKSLQNVNGNTYLY|IGKV2-24|6|DIVMTQSPATLSLSPGERATLSC|IGKV3D-7|1|RMSNLNS|IGLV3-9|3|WFQQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>obiltoxaximab_VL|RASQDIRNYLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLLP|IGKV1-NL1|4|WYQQKPGKAVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>obinutuzumab_VL|RSSKSLLHSNGITYLY|IGKV2D-26|3|DIVMTQTPLSLPVTPGEPASISC|IGKV2-40/IGKV2D-40|0|QMSNLVS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>obrindatamab_VL|KASQNVDTNVA|IGKV3-15/IGKV3D-15|5|DIQLTQSPSFLSASVGDRVTITC|IGKV1-9|0|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGKAPKALIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>obrindatamab_VL_1|RSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>ocaratuzumab_VL|RASSSVPYIH|||EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|ATSALAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ociperlimab_VL|KASQDVGTSVA|IGKV1-NL1|6|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|WASARHT|IGKV3-11/IGKV3D-11|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ocrelizumab_VL|RASSSVSYMH|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|APSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKPLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>odesivimab_VL|KSSQSVLYSSNNKNYLA|IGKV4-1|0|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>odronextamab_VL|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>odronextamab_VL_1|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ofatumumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ogalvibart_VL|RASQSISNWLA|IGKV1-5|1|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|EASSLES|IGKV1-5/IGKV1D-13|1|WFQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>olaratumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>oleclumab_VL|SGSLSNIGRNPVN|IGLV1-36|3|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|LDNLRLS|IGLV6-57|3|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>olendalizumab_VL|RASESVDSYGNSFMH|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|RASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>olinvacimab_VL|RGDNLGDVNVH|IGLV3-9|5|NFMLTQPPSVSVSPGKTARITC|IGLV3-10|4|YDADRPS|IGLV3-21|1|WYQQRPGQAPVLVMY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|2
>oloctinebart_VL|KSSKSLLHSDGITYLY|IGKV2D-29|2|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|RMSNLAS|IGKV2-28/IGKV2D-28|3|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>olokizumab_VL|QASQDIGISLS|IGKV1-33/IGKV1D-33|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NANNLAD|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>omalizumab_VL|RASQSVDYDGDSYMN|||DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASYLES|IGKV1-NL1|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>omburtamab_VL|RASQSISDYLH|IGKV1-39/IGKV1D-39|2|DIVMTQSPATLSVTPGDRVSLSC|IGKV3-15/IGKV3D-15|5|YASQSIS|IGKV6-21/IGKV6D-21|1|WYQQKSHESPRLLIK|IGKV6-21/IGKV6D-21|4
>omodenbamab_VL|RASQSINTYLN|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASIGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|GASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPRLLIA|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>omoprubart_VL|GATENIYGALN|IGKV1-33/IGKV1D-33|7|EIVMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|GASNRYT|IGKV3-11/IGKV3D-11|2|WYQHEPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>onartuzumab_VL|KSSQSLLYTSSQKNYLA|IGKV4-1|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASTRES|IGKV4-1|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>onfekafusp_VL|RASQSVSSSFLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|YASSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ongericimab_VL|QASQDINKYID|IGKV1-33/IGKV1D-33|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YASTLQP|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQHKPGKAPKLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>ontamalimab_VL|KSSQSLLHTDGTTYLY|IGKV2D-29|2|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|EVSNRFS|IGKV2D-26/IGKV2D-29|0|WYLQKPGQPPQLLIY|IGKV2D-29|0
>ontuxizumab_VL|RASQNVGTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASNRYT|IGKV3-11/IGKV3D-11|2|WLQQTPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>onvatilimab_VL|RASQSIDTRLN|IGKV1-39/IGKV1D-39|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>opelkibart_VL|RSSQGIRSDLG|IGKV1-17/IGKV1-6|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>opicinumab_VL|RASQSVSSYLA|IGKV3-11|0|DIQMTQSPATLSLSPGERATLSC|IGKV3D-7|2|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>oportuzumab_VL|RSTKSLLHSNGITYLY|IGKV2D-26|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|QMSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>opucolimab_VL|SGSSSYIESSYVG|IGLV1-47|4|QSVVTQPPSMSAAPGQRVTISC|IGLV1-40|3|DDDMRPS|IGLV1-36|3|WYQQLPGTAPRLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|1
>ordesekimab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASRRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>orilanolimab_VL|KASDHINNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATSLET|IGKV1-33/IGKV1D-33|3|WYQQKPGQAPRLLIS|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>ormutivimab_VL|TGTSSDIGGYNFVS|IGLV2-11/IGLV2-14/IGLV2-8|2|QSALTQPRSVSGSPGQSVTISC|IGLV2-11|0|DATKRPS|IGLV1-51|2|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>orticumab_VL|SGSNTNIGKNYVS|IGLV1-51|3|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|ANSNRPS|IGLV1-40|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>osemitamab_VL|KSSQSLLNSGNLKNYLT|IGKV4-1|5|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRKS|IGKV4-1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>osocimab_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>otelixizumab_VL|TLSSGNIENNYVH|IGLV1-51|5|DIQLTQPNSVSTSLGSTVKLSC|IGLV4-60|9|DDDKRPD|IGLV1-51|3|WYQLYEGRSPTTMIY|IGLV6-57|5
>otilimab_VL|SGDSIGKKYAY|IGLV3-10|3|DIELTQPPSVSVAPGQTARISC|IGLV3-10|4|KKRPS|||WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>otlertuzumab_VL|RASENVYSYLA|IGKV3-11|3|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|FAKTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>oxelumab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>ozanezumab_VL|RSSKSLLYKDGKTYLN|IGKV2-30/IGKV2D-30|4|DIVMTQSPLSNPVTLGQPVSISC|IGKV2-24|3|LMSTRAS|IGKV2-28/IGKV2D-28|2|WFLQRPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>ozuriftamab_VL|SATSSVSYMH|||AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|GTSNLAS|IGKV2-28/IGKV2D-28|3|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>pabinafusp_VL|RSSQSLVHSNGNTYLH|IGKV2-24|2|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>pacanalotamab_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLHT|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pacanalotamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>pacmilimab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>palivizumab_VL|KCQLSVGYMH|||DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pamrevlumab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>pamvatamig_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pamvatamig_VL_1|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>panitumumab_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASNLET|IGKV1-33/IGKV1D-33|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>panobacumab_VL|RSSQSLVYSDGNTYLN|IGKV2-30/IGKV2D-30|0|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|KVSNRDS|IGKV2-30|0|WFQQRPGQSPRRLIY|IGKV2-30/IGKV2D-30|0
>paridiprubart_VL|RASQSISDHLH|IGKV1-39/IGKV1D-39|3|EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|YASHAIS|IGKV1D-43|3|WYQQKPDQSPKLLIK|IGKV6-21/IGKV6D-21|0
>parsatuzumab_VL|RTSQSLVHINAITYLH|IGKV2-24|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|RVSNRFS|IGKV2D-26/IGKV2D-29|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pasotuxizumab_VL|KASQNVDTNVA|IGKV3-15/IGKV3D-15|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGQAPKSLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>pasotuxizumab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>patecibart_VL|RASQNIGTSIH|IGKV6-21/IGKV6D-21|3|EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|YASKSIS|IGKV6-21/IGKV6D-21|2|WYQQKPDQYPKLLIK|IGKV6-21/IGKV6D-21|1
>pateclizumab_VL|RASQAVSSAVA|IGKV1D-13|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASHRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>patritumab_VL|RSSQSVLYSSSNRNYLA|IGKV4-1|3|DIEMTQSPDSLAVSLGERATINC|IGKV4-1|1|WASTRES|IGKV4-1|0|WYQQNPGQPPKLLIY|IGKV4-1|1
>pavurutamab_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLHT|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pavurutamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>pelgifatamab_VL|RASQGISNYLA|IGKV1-16/IGKV1-27|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|EASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQKTGKVPKFLIY|IGKV1-27|2
>pembrolizumab_VL|RASKGVSTSGYSYLH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|LASYLES|IGKV1-5/IGKV1D-13|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>pemivibart_VL|TGSSSNIGAGYDVH|IGLV1-40|0|QSVLTQPPSVSGAPGQRITISC|IGLV1-40|1|GSSSRNS|IGKV3-20|3|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>penpulimab_VL|RASQDINTYLS|IGKV1-16/IGKV1-27|4|DIQMTQSPSSMSASVGDRVTFTC|IGKV1-12/IGKV1D-12|2|RANRLVS|IGKV1-NL1|3|WFQQKPGKSPKTLIY|IGKV1-16|2
>pepinemab_VL|KASQSVDYDGDSYMN|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|AASNLES|IGKV1-NL1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>perakizumab_VL|RASQDINSYLS|IGKV1-39/IGKV1D-39|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|RANRLVD|IGKV1-NL1|4|WFQQKPGKAPKSLIV|IGKV1-16|1
>perenostobart_VL|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>peresolimab_VL|QASQSPNNLLA|IGKV1-16/IGKV1-27|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASDLPS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pertuzumab_VL|KASQDVSIGVA|IGKV3-11|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>petosemtamab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>petosemtamab_VL_1|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pexelizumab_VL|GASENIYGALN|IGKV1-33/IGKV1D-33|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATNLAD|IGKV1-33/IGKV1D-33|4|WYQRKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>picankibart_VL|RASQSISDYLH|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YASQSMS|IGKV6-21/IGKV6D-21|1|WYQQKPGKAPKLLIK|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>pidilizumab_VL|SARSSVSYMH|||EIVLTQSPSSLSASVGDRVTITC|IGKV1D-13|2|RTSNLAS|IGKV2-28/IGKV2D-28|3|WFQQKPGKAPKLWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>pimivalimab_VL|RASQSISSWLA|IGKV1-5|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|EASSLES|IGKV1-5/IGKV1D-13|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pimurutamab_VL|RASQSIGTNIH|IGKV6-21/IGKV6D-21|3|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|YASESIS|IGKV6-21/IGKV6D-21|2|WYQQKPGQAPRLLIK|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>pinatuzumab_VL|RSSQSIVHSVGNTFLE|IGKV2-24|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|KVSNRFS|IGKV2-24|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pivekimab_VL|RASQDINSYLS|IGKV1-39/IGKV1D-39|3|EIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|RVNRLVD|IGKV1-NL1|5|WFQQKPGKAPKTLIY|IGKV1-16|1
>placulumab_VL|RASQAIDSYLH|IGKV1-39/IGKV1D-39|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASNLET|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>plamotamab_VL|RASSSVSYIH|||QIVLTQSPSSLSASVGDRVTITC|IGKV1D-13|2|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGKSPKPLIY|IGKV1-16|2
>plamotamab_VL_1|GSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGKSPRGLIG|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|5
>plonmarlimab_VL|KANQNVGTTLA|IGKV3-11|6|DIQLTQSPSFLSASVGDRVTITC|IGKV1-9|0|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGKSPKALIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>plozalizumab_VL|KSSQSLLDSDGKTFLN|IGKV2D-29|3|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|LVSKLDS|IGKV2-30|3|WFQQRPGQSPRRLIY|IGKV2-30/IGKV2D-30|0
>plutavimab_VL|RASQGISTWLV|IGKV1-12/IGKV1D-12/IGKV1D-16|2|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|GASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPNLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>polatuzumab_VL|KASQSVDYEGDSFLN|||DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASNLES|IGKV1-NL1|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>polzastobart_VL|RASEDIYNDLA|IGKV1-16/IGKV1-27|4|DIQMTQSPSSLSTSVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|NANSLHT|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ponezumab_VL|KSSQSLLYSDAKTYLN|IGKV2D-29|3|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|QISRLDP|IGKV1-NL1|4|WFQQRPGQSPRRLIY|IGKV2-30/IGKV2D-30|0
>ponsegromab_VL|RTSQSVHNYLA|IGKV3-11|3|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASTRAD|IGKV3-11/IGKV3D-11|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>porgaviximab_VL|RASENIYSSLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQMTQSPASLSVSVGETVSITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|5|SATILAD|IGKV5-2|4|WYQQKQGKSPQLLVY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>posdinemab_VL|KASQDINRYLN|IGKV1-33/IGKV1D-33|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|RANRLLD|IGKV1-NL1|4|WFQQKPGKAPKSLIY|IGKV1-16|0
>pozelimab_VL|RASQGIRNDLG|IGKV1-17/IGKV1-6|0|AIQMTQSPSSLSASVGDRVTITC|IGKV1-6|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>pradusinstobart_VL|KAGQNVNNYLA|IGKV1-16/IGKV1-27|5|NIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|NANSLQT|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>prafnosbart_VL|LASSSVSYMT|||EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGQSPRLWIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|2
>praluzatamab_VL|RSSKSLLHSNGITYLY|IGKV2D-26|3|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|QMSNLAS|IGKV2-28/IGKV2D-28|3|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>prasinezumab_VL|KSIQTLLYSSNQKNYLA|IGKV4-1|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASIRKS|IGKV4-1|2|WFQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>prezalumab_VL|RASQGISNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>pritoxaximab_VL|KASQDVGTAVA|IGKV1D-13|6|DIVMSQSHKFMSTSVGDRVSITC|IGKV1-12/IGKV1D-12|8|WASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQNPGQSPKFLIY|IGKV4-1|3
>pritumumab_VL|RASQDISNYLA|IGKV1-16/IGKV1-27|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLHS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WFQQKPGKAPKSLIY|IGKV1-16|0
>prolgolimab_VL|GGNNIGSKNVH|IGLV3-9|0|QPVLTQPLSVSVALGQTARITC|IGLV3-9|3|RDSNRPS|IGLV3-9|0|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>pucotenlimab_VL|RASESVDNYGISFMN|||DIVLTQSPASLAVSPGQRATITC|IGKV4-1|5|AASNKGT|IGKV1-33/IGKV1D-33|3|WFQQKPGQPPKLLIY|IGKV4-1|1
>pulocimab_VL|RASQGLDNWLG|IGKV1-17/IGKV1-6|3|DIQMTQSPSSVSASIGDRVTITC|IGKV1-12/IGKV1D-12|1|DASNLDT|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>puxitatug_VL|RASQDIRNDVG|IGKV1-17/IGKV1-6|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASRLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKRLIY|IGKV1-17|0
>quavonlimab_VL|RTSENIYGGLN|IGKV1-39/IGKV1D-39|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQRKPGKSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>quetmolimab_VL|RASGNIHNFLA|IGKV1-16/IGKV1-27|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NEKTLAD|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|5|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>quilizumab_VL|RSSQSLVHNNANTYLH|IGKV2-24|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|KVSNRFS|IGKV2-24|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>quisovalimab_VL|RASQGINSAFA|IGKV1D-13|2|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|DASSLES|IGKV1-5/IGKV1D-13|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>racotumomab_VL|RASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQTTSSLSASLGDRVTISC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|YTSRLHS|IGKV1-NL1|3|WYQQKPDGTVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>rademikibart_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>radretumab_VL|RASQSVSSSFLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|YASSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>rafivirumab_VL|TGTSSDIGGYNFVS|IGLV2-11/IGLV2-14/IGLV2-8|2|QSALTQPRSVSGSPGQSVTISC|IGLV2-11|0|DATKRPS|IGLV1-51|2|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>ragifilimab_VL|KSSQSLLNSGNQKNYLT|IGKV4-1|5|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>ragistomig_VL|KASQDVTPAVA|IGKV1D-13|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|STSSRYT|IGKV3-20|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ragistomig_VL_1|SGSSSNIGNNYVT|IGLV1-51|1|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|ADSHRPS|IGLV3-1|2|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>ralpancizumab_VL|KASQDVHTAVA|IGKV1D-13|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|HASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>raludotatug_VL|KASQNIYKNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DANTLQT|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ralzapastotug_VL|KASQDVRTAVA|IGKV1D-13|6|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ramucirumab_VL|RASQGIDNWLG|IGKV1-17/IGKV1-6|2|DIQMTQSPSSVSASIGDRVTITC|IGKV1-12/IGKV1D-12|1|DASNLDT|IGKV1-33/IGKV1D-33|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ranevetmab_VL|RASEDIYNALA|IGKV1-16/IGKV1-27|4|DIVMTQSPASLSLSQGETVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|6|NTDTLHT|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|5|WYQQKPGQAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>ranibizumab_VL|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|FTSSLHS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>ravagalimab_VL|KSSQSLLNRGNQKNYLT|IGKV4-1|6|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WFQQKPGQPPKLLIY|IGKV4-1|1
>ravulizumab_VL|GASENIYGALN|IGKV1-33/IGKV1D-33|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATNLAD|IGKV1-33/IGKV1D-33|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>recaticimab_VL|KSSQSLLNSRTRKNFLA|IGKV4-1|6|DIVMSQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|WASTRES|IGKV4-1|0|WYQQKPGKSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>refanezumab_VL|KSSHSVLYSSNQKNYLA|IGKV4-1|2|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>reflocibart_VL|RASQDISNFLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSTLHS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>regdanvimab_VL|SGSSSNIGNNYVS|IGLV1-51|0|ELVLTQPPSVSAAPGQKVTISC|IGLV1-51|2|DNNKRPS|IGLV1-51|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>relatlimab_VL|RASQSISSYLA|IGKV1-39/IGKV1D-39|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>relfovetmab_VL|RASENIYSFLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|EIQMTQSPSSLSASPGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|NANTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGKVPKLLIY|IGKV1-27|0
>remternetug_VL|RASQSLGNWLA|IGKV1-5|3|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|QASTLES|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>remtolumab_VL|RASQGIRNYLA|IGKV1-16/IGKV1-27|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>remtolumab_VL_1|RASQDIGSELH|IGKV6-21/IGKV6D-21|2|EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|YASHSTS|IGKV6-21/IGKV6D-21|2|WYQQKPDQPPKLLIK|IGKV6-21/IGKV6D-21|1
>renvistobart_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>reozalimab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>reozalimab_VL_1|SGSSSNIGSNTVN|IGLV1-44|0|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|GNSNRPS|IGLV1-40|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>reslizumab_VL|LASEGISSYLA|IGKV1-8/IGKV1-9|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GANSLQT|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>resugosbart_VL|KASQSVSNDVA|IGKV3-11|4|DIVMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|YTSNRFT|IGKV2-24|3|WYQQKPGKSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>retifanlimab_VL|RASESVDNYGMSFMN|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGQPPKLLIH|IGKV4-1|2
>retlirafusp_VL|RASESVSIHGTHLMH|||DIVLTQSPASLAVSPGQRATITC|IGKV4-1|5|AASNLES|IGKV1-NL1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>revdofilimab_VL|KASQSVDYDGDSYMH|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|AASILES|IGKV1-NL1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>rezetamig_VL|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>rezetamig_VL_1|RASQSVSSNLA|IGKV3-15/IGKV3D-15|0|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>rezorstobart_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQLTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|1|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>riliprubart_VL|KASQSVDYDGDSYMN|||DIVLTQSPDSLAVSLGERATISC|IGKV4-1|2|DASNLES|IGKV1-33/IGKV1D-33|1|WYQQKPGQPPKILIY|IGKV4-1|1
>rilotumumab_VL|RASQSVDSNLA|IGKV3-15/IGKV3D-15|1|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYRQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>riltovetbart_VL|KASQSVSFAGTGLMH|||EIVMTQSPASLSLSQEEKVTITC|IGKV3D-7|7|RASNLEA|IGKV1-33/IGKV1D-33|2|WYQQKPGQAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>rilvegostomig_VL|SASSKHTNLYWSRHMY|IGKV2D-26|14|QIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|LTSNRAT|IGKV2-28/IGKV2D-28|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>rilvegostomig_VL_1|SGSSSNIGRRPVN|IGLV1-36|3|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|SQNQRPS|IGLV1-44|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>rinucumab_VL|RASQSISSIYLA|IGKV3-20|2|EIVLTQSPDTISLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|2|GASSRVT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ripertamab_VL|RASSSVSYIH|||QIVLSQSPAILSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGSSPKPWIY|IGKV1-16|4
>risankizumab_VL|KASRDVAIAVA|IGKV1D-13|7|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGKVPKLLIY|IGKV1-27|0
>rituximab_VL|RASSSVSYIH|||QIVLSQSPAILSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGSSPKPWIY|IGKV1-16|4
>rivabazumab_VL|RASEGVDRWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQLTQSPSTLSASVGDSVTITC|IGKV1-5|2|DASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQKPGRAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>robatumumab_VL|RASQSIGSSLH|IGKV6-21/IGKV6D-21|0|EIVLTQSPGTLSVSPGERATLSC|IGKV3-20|1|YASQSLS|IGKV6-21/IGKV6D-21|1|WYQQKPGQAPRLLIK|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>rocatinlimab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>roconkibart_VL|RSSQSLVHSNGNSYLH|IGKV2-24|3|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>roledumab_VL|RASQDIRNYVA|IGKV1-16/IGKV1-27|3|AIRMTQSPSSFSASTGDRVTITC|IGKV1-8|0|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKSGKAPKFLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>rolinsatamab_VL|KASQYVGTAVA|IGKV1D-13|6|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|SASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPGKSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>rolistobart_VL|RASEKVDSFGQSFMH|||DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|LTSNLDS|IGKV2-28/IGKV2D-28|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>romilkimab_VL|RASESVDSYGQSYMH|||DIVLTQSPASLAVSLGQRATISC|IGKV4-1|4|LASNLES|IGKV1-33/IGKV1D-33|2|WYQQKAGQPPKLLIY|IGKV4-1|1
>romilkimab_VL_1|HASQNIDVWLS|IGKV1-12/IGKV1D-12/IGKV1D-16|5|DIQMTQSPASLSVSVGDTITLTC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|5|KASNLHT|IGKV1-33/IGKV1D-33|2|WFQQKPGNIPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>romlusevimab_VL|GGNNIGSKSVH|IGLV3-21|0|SYVLTQPPSVSVAPGKTARITC|IGLV3-21|0|YDSDRPS|IGLV3-21|0|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>romosozumab_VL|RASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLLS|IGKV1-NL1|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>rontalizumab_VL|RASQSVSTSSYSYMH|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGKAPKVLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>rosmantuzumab_VL|KASQSVDYDGDSYMN|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASNLES|IGKV1-NL1|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>rosnilimab_VL|TASSSVSSSYFH|IGKV3-20|4|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|STSNLAS|IGLV7-43|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>rosopatamab_VL|KASQDVGTAVD|IGKV5-2|6|DIQMTQSPSSLSTSVGDRVTLTC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|WASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGPSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>rovalpituzumab_VL|KASQSVSNDVV|IGKV3-11|5|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|YASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>rovelizumab_VL|RASESVESYGNNFMY|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|LASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>rozanolixizumab_VL|KSSQSLVGASGKTYLY|IGKV2D-29|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|LVSTLDS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WLFQKPGKAPKRLIY|IGKV1-17|2
>rozibafusp_VL|RASQGISNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>rulonilimab_VL|RASESVDDYGISFMN|||EIVLTQSPATLAVSPGERATISC|IGKV3-11/IGKV3D-11/IGKV3D-20|3|VASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WFQQKPGQPPKLLIY|IGKV4-1|1
>runimotamab_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>runimotamab_VL_1|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ruplizumab_VL|RASQRVSSSTYSYMH|||DIVLTQSPATLSVSPGERATISC|IGKV3-11/IGKV3D-11/IGKV3D-20|3|YASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIK|IGKV4-1|1
>sabatolimab_VL|RASESVEYYGTSLMQ|||AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|AASNVES|IGKV1-NL1|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>sabestomig_VL|SASSKHTNLYWSRHMY|IGKV2D-26|14|QIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|LTSNRAT|IGKV2-28/IGKV2D-28|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>sabestomig_VL_1|GGDNIGGKSVH|IGLV3-21|2|SYVLTQPPSVSVAPGKTARITC|IGLV3-21|0|YDSDRPS|IGLV3-21|0|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>sabirnetug_VL|RSSQSIVHSNGNTYLE|IGKV2-24|3|DVVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|1|KASNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>sacituzumab_VL|KASQDVSIAVA|IGKV1D-13|5|DIQLTQSPSSLSASVGDRVSITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>samalizumab_VL|KASQDINSYLS|IGKV1-33/IGKV1D-33|4|DIQMTQSPSSLSASIGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|RANRLVD|IGKV1-NL1|4|WFQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>samrotamab_VL|RASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLHS|IGKV1-NL1|3|WYQQKPGGAVKFLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>sarilumab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|GASSLES|IGKV1-5/IGKV1D-13|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>sasanlimab_VL|KSSQSLWDSGNQKNFLT|IGKV4-1|7|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WTSYRES|IGKV4-1|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>satralizumab_VL|QASTDISSHLN|IGKV1-33/IGKV1D-33|3|DIQMTQSPSSLSASVGDSVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|YGSHLLS|IGKV1D-43|3|WYQQKPGKAPELLIY|IGKV1D-8|0
>satumomab_VL|RASENIYSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQMTQSPASLSVSVGETVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|AATNLAD|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|4|WYQQKQGKSPQLLVY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>secukinumab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>selicrelumab_VL|RASQGIYSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|TASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQKPGKAPNLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>semorinemab_VL|RSSQSIVHSNGNTYLE|IGKV2-24|3|DDVLTQTPLSLPVTPGQPASISC|IGKV2-40/IGKV2D-40|3|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>semzuvolimab_VL|KAGQSVDYDGDSYMN|||DIVLTQSPASLAVSLGQRATITC|IGKV4-1|4|VASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>seniprutug_VL|KASKSINKYLA|IGKV1-16/IGKV1-27|5|DIQMTQSPYSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|DGSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WFQQKPGKPNKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>serclutamab_VL|HSSQDINSNIG|IGKV1-12/IGKV1D-12/IGKV1D-16|7|DIQMTQSPSSMSVSVGDRVTITC|IGKV1-12/IGKV1D-12|2|HGTNLDD|IGKV1-33/IGKV1D-33|5|WLQQKPGKSFKGLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>seribantumab_VL|TGTSSDVGSYNVVS|IGLV2-18|1|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|EVSQRPS|IGLV2-14/IGLV2-18|1|WYQQHPGKAPKLIIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|1
>serplulimab_VL|KASQDVTTAVA|IGKV1D-13|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>setoxaximab_VL|KSSQSLLYSRNQKNYLA|IGKV4-1|3|DIVLSQSPSSLVVSVGEKVTMSC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|9|WASTRES|IGKV4-1|0|WYQQKPGQSPKVLIY|IGKV4-1|2
>setrusumab_VL|TGTSSDVGDINDVS|IGLV2-11/IGLV2-14/IGLV2-8|3|DIALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|2|DVNNRPS|IGLV1-51|2|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>sibeprenlimab_VL|RASESVDNDGIRFLH|||EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|RASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>sifalimumab_VL|RASQSVSSTYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>sigvotatug_VL|GASENIYGALN|IGKV1-33/IGKV1D-33|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATNLED|IGKV1-33/IGKV1D-33|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>silevimig_VL|RASQNIRNALN|IGKV1-17/IGKV1-6|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASTRQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>silevimig_VL_1|TGTSSDLGGYDFVS|IGLV2-11/IGLV2-14/IGLV2-8|3|QSALTQPRSVSGSPGQSVTISC|IGLV2-11|0|DATKRPS|IGLV1-51|2|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>siltuximab_VL|SASSSVSYMY|||QIVLIQSPAIMSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|9|DTSNLAS|IGLV7-46|2|WYQQKPGSSPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|2
>simaravibart_VL|RASQSVSSYLA|IGKV3-11|0|EIVMTQSPATLSLSPGERATLSC|IGKV3D-7|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPSLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>simlukafusp_VL|RASQSVTSSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|VGSRRAT|IGKV2-28/IGKV2D-28|3|WYQQKPGQAPRLLIN|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>simridarlimab_VL|RASQGISRWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>simtuzumab_VL|RSSKSLLHSNGNTYLY|IGKV2D-26|3|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|RMSNLAS|IGKV2-28/IGKV2D-28|3|WFLQKPGQSPQFLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>sintilimab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>sipavibart_VL|TGTSSDVGGYNYVS|IGLV2-11/IGLV2-14/IGLV2-8|0|QSVVTQPPSASGSLGQSVTISC|IGLV2-8|3|EVSKRPS|IGLV2-8|0|WYQQHPGKAPKLMIF|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|1
>sirexatamab_VL|HASDSISNSLH|IGKV1-NL1|4|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|YARQSIQ|IGKV6-21/IGKV6D-21|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>sirtratumab_VL|RSSQSLLLSHGFNYLD|IGKV2-28/IGKV2D-28|3|DIVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|0|LGSSRAS|IGKV2-28/IGKV2D-28|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>sirukumab_VL|SASISVSYMY|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DMSNLAS|IGKV1-33/IGKV1D-33|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>socazolimab_VL|TGSSSDVGSYNLVS|IGLV2-23|1|QSALTQPASVSGSLGQSVTISC|IGLV2-11|2|DVSKRS|||WYQQHPGKAPNLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|1
>sofituzumab_VL|KASDLIHNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GATSLET|IGKV1-33/IGKV1D-33|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>solanezumab_VL|RSSQSLIYSDGNAYLH|IGKV2-30/IGKV2D-30|3|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|KVSNRFS|IGKV2-24|1|WFLQKPGQSPRLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>solitomab_VL|KSSQSLLNSGNQKNYLT|IGKV4-1|5|ELVMTQSPSSLTVTAGEKVTMSC|IGKV2-28/IGKV2D-28|9|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>solitomab_VL_1|RASQSVSYMN|||DIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|DTSKVAS|IGLV2-11|3|WYQQKPGKAPKRWIY|IGKV1-17|1
>solrikitug_VL|RASQPISISVH|IGKV1-NL1|4|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|FASQSIS|IGKV6-21/IGKV6D-21|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>sotevtamab_VL|KSSQSLLNSRTRKNYLA|IGKV4-1|5|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>sotiburafusp_VL|KSSQSLANSYGNTYLS|IGKV2-24|4|DVVMTQTPLSLSVTPGQPASISC|IGKV2D-29|1|GISNRFS|IGKV2-24|1|WYLHKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>sotigalimab_VL|QASQSISSRLA|IGKV1-5|2|DIQMTQSPSSLSASVGDRVTIKC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|RASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKPPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>sotrovimab_VL|RASQTVSSTSLA|IGKV3-20|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>sovipostobart_VL|RASQSVGSSYLA|IGKV3-20|1|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GAFSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>spartalizumab_VL|KSSQSLLDSGNQKNFLT|IGKV4-1|6|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|WASTRES|IGKV4-1|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>spesolimab_VL|TASSSVSSSYFH|IGKV3-20|4|QIVLTQSPGTLSLSPGERATMTC|IGKV3-20|3|RTSRLAS|IGKV1-NL1|3|WYQQKPGQAPRLWIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>stamulumab_VL|SGHALGDKFVS|IGLV3-1|5|SYELTQPPSVSVSPGQTASITC|IGLV3-1|0|DDTQRPS|IGLV6-57|2|WYQQKPGQSPVLVIY|IGLV3-1|0
>stapokibart_VL|QASQDISNYLN|IGKV1-33/IGKV1D-33|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLHS|IGKV1-NL1|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>suciraslimab_VL|RASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQLTQTTSSLSASLGDRVTISC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|5|YTSILHS|IGKV1D-43|3|WYQQKPDGTVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>sudubrilimab_VL|RASQDVSTAVA|IGKV1D-13|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>sugemalimab_VL|GGNNIGSKSVH|IGLV3-21|0|SYVLTQPPSVSVAPGQTARITC|IGLV3-21|1|DDSDRPS|IGLV3-21|1|WYQQKPGQAPVLVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>suptavumab_VL|RASQTILSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|3|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYLQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>surzebiclimab_VL|RASESVEYYGTSLMQ|||EIVLTQSPATLSVSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|AASNVES|IGKV1-NL1|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>sutimlimab_VL|TASSSVSSSYLH|IGKV3-20|3|QIVLTQSPATLSLSPGERATMSC|IGKV3-11/IGKV3D-11/IGKV3D-20|2|STSNLAS|IGLV7-43|2|WYQQKPGKAPKLWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>suvemcitug_VL|QASQSIYNNNELS|IGLV1-51|8|DIQMTQSPSSLSASVGDRVTINC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|RASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKPPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>suvizumab_VL|KSSQSLLNSGDQKNYLT|IGKV4-1|6|DIQMTQRPDSLSASVGDRVTMSC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|WASTGES|IGKV4-1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>suvratoxumab_VL|RASQSISSWLA|IGKV1-5|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASSLES|IGKV1-5/IGKV1D-13|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tabalumab_VL|RASQSVSRYLA|IGKV3-11|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>tabituximab_VL|RASENIYSNLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQMTQSPASLSVSVGETVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|VATNLAD|IGKV1-33/IGKV1D-33|4|WYQQKQGKSPQLLVY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>tacatuzumab_VL|KASQDINKYIG|IGKV1-33/IGKV1D-33|5|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|YTSALLP|IGKV1D-43|4|WYQQKPGKAPKLLMH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>tadocizumab_VL|RASQDINNYLN|IGKV1-33/IGKV1D-33|2|DIQMTQTPSTLSASVGDRVTISC|IGKV1-5|2|YTSTLHS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tafasitamab_VL|RSSKSLQNVNGNTYLY|IGKV2-24|6|DIVMTQSPATLSLSPGERATLSC|IGKV3D-7|1|RMSNLNS|IGLV3-9|3|WFQQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>tafolecimab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>tagitanlimab_VL|RASQSIGTNIH|IGKV6-21/IGKV6D-21|3|EIVLTQSPDTLSVTPKEKVTLTC|IGKV6-21/IGKV6D-21|3|YASESIS|IGKV6-21/IGKV6D-21|2|WFQQKPGQSPKLLIK|IGKV6-21/IGKV6D-21|2
>talacotuzumab_VL|ESSQSLLNSGNQKNYLT|IGKV4-1|6|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKPLIY|IGKV4-1|1
>talizumab_VL|RASQSIGTNIH|IGKV6-21/IGKV6D-21|3|DILLTQSPGTLSLSPGERATLSC|IGKV3-20|2|YASESIS|IGKV6-21/IGKV6D-21|2|WYQQKPGQAPRLLIK|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>talquetamab_VL|KASQNVATHVG|IGKV1-17/IGKV1-6|7|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGKAPKRLIY|IGKV1-17|0
>talquetamab_VL_1|RSSTGAVTTSNYAN|IGLV7-43|5|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>tamgiblimab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>tamrintamab_VL|TASSSVNSFYLH|IGKV3-20|5|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|STSNLAS|IGLV7-43|2|WYQQKPGLAPRLLIY|IGKV3D-20|0
>tamtuvetmab_VL|KASQNIDKYLN|IGKV1-33/IGKV1D-33|4|DIKMTQSPSFLSASVGDRVTLNC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|NTNNLQT|IGKV1-33/IGKV1D-33|4|WYQQKLGESPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>tanezumab_VL|RASQSISNNLN|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRFHS|IGLV7-43|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tarcocimab_VL|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|FTSSLHS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>tarextumab_VL|RASQSVRSNYLA|IGKV3-20|2|DIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>tarlatamab_VL|RASQRVNNNYLA|IGKV3-20|4|EIVLTQSPGTLSLSPGERVTLSC|IGKV3-20|1|GASSRAT|IGKV3-20|0|WYQQRPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>tarlatamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>tavolimab_VL|RASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSKLHS|IGKV1D-43|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tebentafusp_VL|RASQDIRNYLN|IGKV1-33/IGKV1D-33|2|AIQMTQSPSSLSASVGDRVTITC|IGKV1-6|0|YTSRLES|IGKV1-NL1|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tebotelimab_VL|RASESVDNYGMSFMN|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGQPPKLLIH|IGKV4-1|2
>tebotelimab_VL_1|RASQDVSSVVA|IGKV3-11|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tecaginlimab_VL|SASQGINNYLN|IGKV1-16/IGKV1-27|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSSLHS|IGKV1D-43|2|WYQQKPGKAVKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>tecaginlimab_VL_1|QASEDISSYLA|IGKV1-33/IGKV1D-33|3|DIVMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|GASDLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKRLIY|IGKV1-17|0
>teclistamab_VL|GGNNIGSKSVH|IGLV3-21|0|SYVLTQPPSVSVAPGQTARITC|IGLV3-21|1|DDSDRPS|IGLV3-21|1|WYQQPPGQAPVVVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|3
>teclistamab_VL_1|RSSTGAVTTSNYAN|IGLV7-43|5|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>tegoprubart_VL|RASQRVSSSTYSYMH|||DIVLTQSPATLSVSPGERATISC|IGKV3-11/IGKV3D-11/IGKV3D-20|3|YASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIK|IGKV4-1|1
>telazorlimab_VL|RASSSVSYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|ATSNRAT|IGKV3-11/IGKV3D-11|2|WYQQKPGQAPRPWIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|2
>telisotuzumab_VL|KSSESVDSYANSFLH|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|RASTRES|IGKV4-1|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>temelimab_VL|SASSSVSYMY|||QIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|1|RTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGKAPKAWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>temtokibart_VL|QGGYYAH|||SQELTQPSSVSVALGQTARITC|IGLV3-9|2|GQNNRPS|IGLV3-19|1|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>tenatumomab_VL|RSSKSLLHSNGNTYLY|IGKV2D-26|3|DIVMTQAAPSVPVTPGESVSISC|IGKV2-28/IGKV2D-28|6|RMSNLAS|IGKV2-28/IGKV2D-28|3|WFLQRPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|2
>teneliximab_VL|RASQSISDYLH|IGKV1-39/IGKV1D-39|2|DIVLTQSPATLSVTPGDRVSLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|6|YASHSIS|IGKV6-21/IGKV6D-21|2|WYQQKSHESPRLLIK|IGKV6-21/IGKV6D-21|4
>teplizumab_VL|SASSSVSYMN|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQTPGKAPKRWIY|IGKV1-17|2
>tepoditamab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tepoditamab_VL_1|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>teprotumumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASKRAT|IGKV3-11/IGKV3D-11|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>teropavimab_VL|QANGYLN|||DIQMTQSPSSLSASVGDTVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|DGSKLER|IGKV1-33/IGKV1D-33|3|WYQQRRGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>tesidolumab_VL|SGDSIPNYYVY|IGLV3-10|5|SYELTQPLSVSVALGQTARITC|IGLV3-9|0|DDSNRPS|IGLV3-12|1|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>tesnatilimab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>tezepelumab_VL|GGNNLGSKSVH|IGLV3-21|1|SYVLTQPPSVSVAPGQTARITC|IGLV3-21|1|DDSDRPS|IGLV3-21|1|WYQQKPGQAPVLVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>tibulizumab_VL|RASQSVSRYLA|IGKV3-11|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>tibulizumab_VL_1|RSSRSLVHSRGETYLH|IGKV2-24|4|DIVMTQTPLSLSVTPGQPASISC|IGKV2D-29|0|KVSNRFI|IGKV2-24|2|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>tidutamab_VL|KSSQSLLNSRNRKNYLA|IGKV4-1|4|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPDQSPKLLIY|IGKV6-21/IGKV6D-21|1
>tidutamab_VL_1|GSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGKSPRGLIG|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|5
>tifcemalimab_VL|KSSQSLLDSDGKTYLN|IGKV2D-29|2|DVVMTQTPLSLSVTPGQPASISC|IGKV2D-29|1|LVSKLDS|IGKV2-30|3|WFQQRPGQSPRRLIY|IGKV2-30/IGKV2D-30|0
>tigatuzumab_VL|KASQDVGTAVA|IGKV1D-13|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tilavonemab_VL|RASQSVSTSRYSYIH|||DIVLTQSPDSLAVSLGERATISC|IGKV4-1|2|YASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIK|IGKV4-1|1
>tildrakizumab_VL|RTSENIYSYLA|IGKV1-8/IGKV1-9|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NAKTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tilogotamab_VL|SASSSVSYMY|||DIQLTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|RTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGKAPKPWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>tilvestamab_VL|RSSQSLVHSNGIPYLH|IGKV2-24|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|RVSNRFS|IGKV2D-26/IGKV2D-29|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>timcevibart_VL|RASQGISSYLA|IGKV1-8/IGKV1-9|0|DIVMTQSPSFLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>timigutuzumab_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>timolumab_VL|RASQGISRALA|IGKV1D-13|1|VIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|1|DASSLES|IGKV1-5/IGKV1D-13|0|WYQQKPGKGPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>tinurilimab_VL|KASQNVGTAVA|IGKV1D-13|6|DIQLTQSPSFLSASVGDRVTITC|IGKV1-9|0|SASNRYT|IGKV3-11/IGKV3D-11|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tiragolumab_VL|KSSQTVLYSSNNKKYLA|IGKV4-1|2|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPNLLIY|IGKV4-1|1
>tirnovetmab_VL|RASESVDTYGNSFMH|||DIVMTQSPASLSVSLGQRATISC|IGKV4-1|4|RASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQSPKLLIY|IGKV4-1|1
>tislelizumab_VL|KSSESVSNDVA|IGKV3-11|6|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|YAFHRFT|IGKV3-11/IGKV3D-11|4|WYQQKPGQPPKLLIN|IGKV4-1|1
>tisotumab_VL|RASQGISSRLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPPSLSASAGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>tixagevimab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>tobemstomig_VL|KASESVDTSDNSFIH|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|RSSTLES|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|3|WYQQKPGQSPKLLIY|IGKV4-1|1
>tobemstomig_VL_1|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tobevibart_VL|SGDKLGNKNVA|IGLV3-1|4|SYELTQPPSVSVSPGQTVSIPC|IGLV3-1|2|EVKYRPS|IGLV2-14/IGLV2-18|2|WFQHKPGQSPVLVIY|IGLV3-1|2
>tocilizumab_VL|RASQDISSYLN|IGKV1-39/IGKV1D-39|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLHS|IGKV1-NL1|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tomaralimab_VL|RASESVEYYGTSLMQ|||DIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|GASNVES|IGKV1-33/IGKV1D-33|3|WYQQKPGQPPKLLIF|IGKV4-1|1
>tomuzotuximab_VL|RASQSIGTNIH|IGKV6-21/IGKV6D-21|3|DILLTQSPVILSVSPGERVSFSC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|YASESIS|IGKV6-21/IGKV6D-21|2|WYQQRTNGSPRLLIK|IGKV6-21/IGKV6D-21|5
>toripalimab_VL|RSSQSIVHSNGNTYLE|IGKV2-24|3|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|KVSNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>torudokimab_VL|RASQSVGINLS|IGKV3-15/IGKV3D-15|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASHRLT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>tosatoxumab_VL|SGGSSNIGSNTVN|IGLV1-44|1|QSVLTQSPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|1|TNNQRPS|IGLV1-44|1|WYQQFPGAAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>tovetumab_VL|RPSQSFSRYIN|IGKV1-39/IGKV1D-39|4|DIQMTQSPSSLSASVGDRVSITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASSLVG|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WYQQKPGKAPKLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>tozorakimab_VL|SGEGMGDKYAA|IGLV3-1|4|SYVLTQPPSVSVSPGQTASITC|IGLV3-1|1|RDTKRPS|IGLV3-1|2|WYQQKPGQSPVLVIY|IGLV3-1|0
>trabikibart_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tralokinumab_VL|GGNIIGSKLVH|IGLV3-12|2|SYVLTQPPSVSVAPGKTARITC|IGLV3-21|0|DDGDRPS|IGLV3-21|2|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>trastuzumab_VL|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>traxivitug_VL|GGDNIGSRPVH|IGLV3-12|3|QSVLTQPPSVSVAPGKTARITC|IGLV3-21|2|DDSNRPS|IGLV3-12|1|WYQQKPGQAPILVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|2
>tregalizumab_VL|RASKSVSTSGYSYIY|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|LASILES|IGKV1-5/IGKV1D-13|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>tremelimumab_VL|RASQSINSYLD|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>trevogrumab_VL|RASQDISDYLA|IGKV1-16/IGKV1-27|2|DIQMTQSPASLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|TTSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKIPRLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>trinbelimab_VL|SGSSSDVGGYKYVS|IGLV2-11/IGLV2-14/IGLV2-8|3|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|DVNNRPS|IGLV1-51|2|WYQQHPGKAPQLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|1
>trontinemab_VL|RASQSVSSSYLA|IGKV3-20|0|DIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|GASSRAT|IGKV3-20|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>trontinemab_VL_1|RASQSISSYLA|IGKV1-39/IGKV1D-39|1|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|RASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>tucotuzumab_VL|SASSSVSYML|||EIVLTQSPATLSLSPGERVTLTC|IGKV3-11/IGKV3D-11/IGKV3D-20|2|DTSNLAS|IGLV7-46|2|WYQQKPGSSPKPWIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|5
>tulisokibart_VL|RASSSVSYMY|||EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQAPRPLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>tuparstobart_VL|SVSSSISSSNLH|IGKV3-20|6|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>tusamitamab_VL|RASENIFSYLA|IGKV1-8/IGKV1-9|3|DIQMTQSPASLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|NTRTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|5|WYQQKPGKSPKLLVY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|2
>tuvonralimab_VL|RASQSINSYLA|IGKV1-39/IGKV1D-39|2|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GVSSRAT|IGKV3-20|1|WYQQKPGQAPRPLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>ubamatamab_VL|RASQSISTYLN|IGKV1-39/IGKV1D-39|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|TASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ubamatamab_VL_1|RASQSISTYLN|IGKV1-39/IGKV1D-39|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|TASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>ublituximab_VL|RASSSVSYMH|||QIVLSQSPAILSASPGEKVTMTC|IGKV3-11/IGKV3D-11/IGKV3D-20|8|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGSSPKPWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
>ucenprubart_VL|QASESIDSYLL|IGKV1-39/IGKV1D-39|4|EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|QASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPDQSPKLLIK|IGKV6-21/IGKV6D-21|0
>ulenistamab_VL|KSSQSLLNSRTRKNYLA|IGKV4-1|5|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>uliledlimab_VL|RASSRVNYMH|||EIVLSQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQSPRPWIS|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|4
>ulocuplumab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>ulviprubart_VL|KSSQTLLYSSDQKNYLA|IGKV4-1|4|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>umesolerbart_VL|RASQSVSSSLA|IGKV3-11|1|EIVMTQSPATLSVSPGERATLSC|IGKV3-15/IGKV3D-15|0|SASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|1|WYQQKPGQAPRRLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>umizortamig1_VL|QASESISSWLA|IGKV1-5|2|DVVMTQSPSTLSASVGDRVTINC|IGKV1-5|3|EASKLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>umizortamig1_VL_1|HSSQDINSNIG|IGKV1-12/IGKV1D-12/IGKV1D-16|7|DILMTQSPSSMSVSLGDTVSITC|IGKV1-12/IGKV1D-12|6|HGTNLDD|IGKV1-33/IGKV1D-33|5|WLQQRPGKSFKGLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|5
>umizortamig2_VL|QASQSISSHLN|IGKV1-39/IGKV1D-39|2|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>umizortamig2_VL_1|QASEDIDTYLA|IGKV1-33/IGKV1D-33|4|ALVMTQSPSTLSASVGDRVTINC|IGKV1-5|4|YASDLAS|IGKV1D-43|2|WYQQKPGKAPKLLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>unasnemab_VL|RASQDISSYLN|IGKV1-39/IGKV1D-39|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|YTSRLHS|IGKV1-NL1|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>upanovimab_VL|RASESVDNYGISFMN|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|AASNQGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>upinitatug_VL|SASQDIGNFLN|IGKV1-33/IGKV1D-33|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSSLYS|IGKV1D-43|2|WYQQKPGKTVKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>uprevstobart_VL|KASQDVSTAVA|IGKV1D-13|5|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGQPPKLLIY|IGKV4-1|0
>urabrelimab_VL|RASESVSSNLA|IGKV3-15/IGKV3D-15|1|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|GAFNRAT|IGKV3-11/IGKV3D-11|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>urelumab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>urtoxazumab_VL|RASQTISNNLH|IGKV1-16/IGKV1-27|3|EIVLTQSPATLSVSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|SASQSIS|IGKV6-21/IGKV6D-21|2|WYQQKPGQAPRLLIK|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>usilnetug_VL|LASQTIGTWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|4|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AATSLAD|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKSPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>ustekinumab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>utomilumab_VL|SGDNIGDQYAH|IGLV3-1|4|SYELTQPPSVSVSPGQTASITC|IGLV3-1|0|QDKNRPS|IGLV3-1|2|WYQQKPGQSPVLVIY|IGLV3-1|0
>vadastuximab_VL|KASQDINSYLS|IGKV1-33/IGKV1D-33|4|DIQMTQSPSSLSASVGDRVTINC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|RANRLVD|IGKV1-NL1|4|WFQQKPGKAPKTLIY|IGKV1-16|1
>valanafusp_VL|RASQDIGGNLY|IGKV6-21/IGKV6D-21|4|DIQMTQSPSSLSASLGERVSLTC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|4|ATSSLDS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|2|WLQQGPDGTIKRLIY|IGKV1-17|6
>vamikibart_VL|RASESVDNYGIPFMN|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|AASNRGS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGQPPKLLIY|IGKV4-1|0
>vandortuzumab_VL|KSSQSLLYRSNQKNYLA|IGKV4-1|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|WASTRES|IGKV4-1|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>vantictumab_VL|SGDNIGSFYVH|IGLV3-12|4|DIELTQPPSVSVAPGQTARISC|IGLV3-10|4|DKSNRPS|IGLV1-40|2|WYQQKPGQAPVLVIY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|0
>vanucizumab_VL|GGNNIGSKSVH|IGLV3-21|0|QPGLTQPPSVSVAPGQTARITC|IGLV3-10|4|DDSDRPS|IGLV3-21|1|WYQQKPGQAPVLVVY|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|1
>vanucizumab_VL_1|SASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|FTSSLHS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>varisacumab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIRMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>varlilumab_VL|RASQGISRWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPEKAPKSLIY|IGKV1D-16|0
>varokibart_VL|GGNNIGSKNVY|IGLV3-9|1|SYVLTQPPSVSVAPGQTARITC|IGLV3-21|1|DDSDRPS|IGLV3-21|1|WYQQKPGQAPVLVVH|IGLV3-19/IGLV3-21/IGLV3-25/IGLV3-9|2
>vatelizumab_VL|SAQSSVNYIH|||DFVMTQSPAFLSVTPGEKVTITC|IGKV6-21/IGKV6D-21|6|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPDQAPKKLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>vedolizumab_VL|RSSQSLAKSYGNTYLS|IGKV2-24|3|DVVMTQSPLSLPVTPGEPASISC|IGKV2-28/IGKV2D-28|1|GISNRFS|IGKV2-24|1|WYLQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|0
>veligrotug_VL|RSSQSIVHSNVNTYLE|IGKV2-24|4|DVVMTQTPLSLPVSLGDPASISC|IGKV2-30/IGKV2D-30|3|KVSNRFS|IGKV2-24|1|WYLQKPGQSPRLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>veltuzumab_VL|RASSSVSYIH|||DIQLTQSPSSLSASVGDRVTMTC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|2|ATSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WFQQKPGKAPKPWIY|IGKV1-16|2
>venanprubart_VL|QASQSISTALA|IGKV1-5|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|AASTLAS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>vensobafusp_VL|RTSKSISKHLA|IGKV1-5|4|DIQLTQSPSFLSASVGDRVTITC|IGKV1-9|0|SGSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>vepsitamab_VL|SGDKLGDKYAS|IGLV3-1|1|SYELTQPSSVSVPPGQTASITC|IGLV3-1|2|QDRKRPS|IGLV3-1|1|WYQQKPGQSPVLVIY|IGLV3-1|0
>vepsitamab_VL_1|GSSTGAVTSGNYPN|IGLV7-43|2|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTKFLAP|IGKV3-15/IGKV3D-15/IGKV3D-7|5|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>verekitug_VL|RASQDISNYLA|IGKV1-16/IGKV1-27|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|TASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WFQQKPGKAPKSLIY|IGKV1-16|0
>verzistobart_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>vesencumab_VL|RASQYFSSYLA|IGKV1-8/IGKV1-9|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASSRAS|IGKV3-20|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>vibecotamab_VL|KSSQSLLNTGNQKNYLT|IGKV4-1|6|DFVMTQSPDSLAVSLGERATINC|IGKV4-1|1|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>vibecotamab_VL_1|GSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGKSPRGLIG|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|5
>vibostolimab_VL|RASEHIYSYLS|IGKV1-39/IGKV1D-39|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NAKTLAE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|4|WYQQKPGKVPKLLIY|IGKV1-27|0
>vilamakitug_VL|KSSQSVLYSSNNKNYLA|IGKV4-1|0|DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>vilastobart_VL|SANSALSYMY|||EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|GTSNLAS|IGKV2-28/IGKV2D-28|3|WYQQKPDQSPKLWVH|IGKV6-21/IGKV6D-21|3
>vilobelimab_VL|KASQSVDYDGDSYMK|||DIVLTQSPASLAVSLGQRATISC|IGKV4-1|4|AASNLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|1|WYQQKPGQPPKLLIY|IGKV4-1|0
>vipalanebart_VL|RASQSIWRWLA|IGKV1-5|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DASQLFE|IGKV1-33/IGKV1D-33|3|WYQQKPGKAPKLLIH|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>visilizumab_VL|SASSSVSYMN|||DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|DTSKLAS|IGKV1-5/IGKV1D-13|3|WYQQKPGKAPKRLIY|IGKV1-17|0
>visugromab_VL|KASQNVGTNVA|IGKV3-15/IGKV3D-15|5|DIVLTQSPSFLSASVGDRVTITC|IGKV1-9|1|SASYRYS|IGKV2-40/IGKV2D-40|3|WFQQKPGKSPKALIY|IGKV1-16|2
>vixarelimab_VL|SGSNSNIGSNTVN|IGLV1-44|1|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|NINKRPS|IGLV1-51|2|WYHQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|1
>vobramitamab_VL|RASESIYSYLA|IGKV1-39/IGKV1D-39|3|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|NTKTLPE|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|5|WYQQKPGKAPKLLVY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>vofatamab_VL|RASQDVDTSLA|IGKV1-NL1|4|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYKQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>volagidemab_VL|RASQGIRNDLG|IGKV1-17/IGKV1-6|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKRLIY|IGKV1-17|0
>volociximab_VL|TASSSVSSNYLH|IGKV3-20|4|QIVLTQSPAIMSASLGERVTMTC|IGKV1-9|8|STSNLAS|IGLV7-43|2|WYQQKPGSAPNLWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|3
>volrustomig_VL|RASQSINSYLD|IGKV1-39/IGKV1D-39|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>volrustomig_VL_1|SASSKHTNLYWSRHMY|IGKV2D-26|14|QIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|1|LTSNRAT|IGKV2-28/IGKV2D-28|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>vonlerolizumab_VL|RASQDISNYLN|IGKV1-33/IGKV1D-33|1|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLRS|IGKV1-NL1|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>vonsetamig_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>vonsetamig_VL_1|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>vopikitug_VL|RASQSISSWLA|IGKV1-5|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASSLES|IGKV1-5/IGKV1D-13|1|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>vopratelimab_VL|KSSQSLLSGSFNYLT|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|YASTRHT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGQPPKLLIF|IGKV4-1|1
>vorsetuzumab_VL|RASKSVSTSGYSFMH|||DIVMTQSPDSLAVSLGERATINC|IGKV4-1|0|LASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGQPPKLLIY|IGKV4-1|0
>voxalatamab_VL|RASQSVSSYLA|IGKV3-11|0|EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|DASNRAT|IGKV3-11/IGKV3D-11|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>voxalatamab_VL_1|RSSTGAVTTSNYAN|IGLV7-43|5|QTVVTQEPSLTVSPGGTVTLTC|IGLV7-43|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGQAPRGLIG|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>vudalimab_VL|RASQSVSSSYLA|IGKV3-20|0|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GAFSRAT|IGKV3-20|1|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>vudalimab_VL_1|RASQSVGNDVA|IGKV3-11|4|EIVLTQSPATLSASPGERVTLTC|IGKV3-11/IGKV3D-11/IGKV3D-20|3|YASHRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGQAPRLLIN|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>vulinacimab_VL|RSSQSLYYRSGYTFLD|IGKV2-28/IGKV2D-28|6|DVVMTQSPLSLPVTLGQPASISC|IGKV2-30/IGKV2D-30|0|QSSKRDS|IGLV3-1|2|WYVQKPGQSPQLLIY|IGKV2-28/IGKV2-40/IGKV2D-28/IGKV2D-40|1
>vunakizumab_VL|SASSSVNYMH|||EIVLTQSPDFQSVTPKEKVTITC|IGKV6-21/IGKV6D-21|0|RTSNLAS|IGKV2-28/IGKV2D-28|3|WFQQKPDQSPKLWIY|IGKV6-21/IGKV6D-21|3
>xaluritamig_VL|RASSSVSYMH|||EIVLTQSPATLSLSPGERATLSC|IGKV3-11/IGKV3D-11/IGKV3D-20|0|STSNLAS|IGLV7-43|2|WFQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|1
>xaluritamig_VL_1|GSSTGAVTTSNYAN|IGLV7-43|5|QAVVTQEPSLTVSPGGTVTLTC|IGLV7-46|0|GTNKRAP|IGKV3-15/IGKV3D-15/IGKV3D-7|4|WVQQKPGKSPRGLIG|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|5
>xeligekimab_VL|RASQNVHNRLT|IGKV1-16/IGKV1-27|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|GASNLES|IGKV1-33/IGKV1D-33|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>xentuzumab_VL|SGSSSNIGSNSVS|IGLV1-44|2|DIVLTQPPSVSGAPGQRVTISC|IGLV1-40|2|DNSKRPS|IGLV1-51|1|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>xirestomig_VL|TGTVSEVGGYNEVS|IGLV2-11/IGLV2-14/IGLV2-8|3|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|GNSNRPS|IGLV1-40|0|WYQQHPGKAPKLMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|0
>xirestomig_VL_1|SGSTSDIGSYSVN|IGLV1-44|4|QSVLTQPPSASGTPGQRVTISC|IGLV1-44/IGLV1-47|0|SNNQRPS|IGLV1-44|0|WYQQLPGTAPKLLIY|IGLV1-40/IGLV1-44/IGLV1-47/IGLV1-51|0
>zagotenemab_VL|RSSQSLVHSNQNTYLH|IGKV2-24|3|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|KVDNRFS|IGKV2-24|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>zalifrelimab_VL|RASQSVSRYLG|IGKV3-11|2|EIVLTQSPGTLSLSPGERATLSC|IGKV3-20|0|GASTRAT|IGKV3-15/IGKV3D-15/IGKV3D-7|0|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>zalutumumab_VL|RASQDISSALV|IGKV1D-13|2|AIQLTQSPSSLSASVGDRVTITC|IGKV1D-13|0|DASSLES|IGKV1-5/IGKV1D-13|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>zamerovimab_VL|KASQNVGTTVA|IGKV3-11|6|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYS|IGKV2-40/IGKV2D-40|3|WYQQKPGKAPKALIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>zampilimab_VL|KASQDINSYLT|IGKV1-33/IGKV1D-33|4|DITMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|1|LVNRLVD|IGKV1-NL1|5|WFQQKPGKAPKILIY|IGKV1-16|1
>zanidatamab_VL|KASQDVSIGVA|IGKV3-11|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASYRYT|IGKV3-11/IGKV3D-11|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>zanidatamab_VL_1|RASQDVNTAVA|IGKV1D-13|5|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|SASFLYS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>zanolimumab_VL|RASQDISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQHKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>zansecimab_VL|KASQDVYIAVA|IGKV1D-13|6|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|WASTRDT|IGKV3-15/IGKV3D-15/IGKV3D-7|2|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>zeleciment_VL|RASQDISNFLN|IGKV1-33/IGKV1D-33|2|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|YTSRLHS|IGKV1-NL1|3|WYQQKPGQPVKLLIY|IGKV4-1|1
>zelminemab_VL|RASQSIGRSLH|IGKV6-21/IGKV6D-21|1|DIQLTQSPSFLSASVGDRVTITC|IGKV1-9|0|YASQSLS|IGKV6-21/IGKV6D-21|1|WYQQKPGKAPKLLIK|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>zeluvalimab_VL|RASQGISNWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|1|DIQMTQSPSSVSASVGDRVTITC|IGKV1-12/IGKV1D-12|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>zenocutuzumab_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>zenocutuzumab_VL_1|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>zeripatamig_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>zeripatamig_VL_1|TRSSGSIEDKYVQ|IGLV6-57|3|NFMLTQPHSVSESPGKTVTISC|IGLV6-57|0|YDNERPS|IGLV3-16/IGLV3-25/IGLV3-27|2|WYQQRPGSSPTIVIY|IGLV6-57|1
>zifibancimig_VL|HGSYWLNSEVA|IGKV1-12/IGKV1D-12/IGKV1D-16|8|AIYMHQEPSSLSASVGDRVTITC|IGKV1-6|3|DGDFKVY|IGLV7-46|5|WYQQKPGKAPKLLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>zifibancimig_VL_1|HGSYWLNSEVA|IGKV1-12/IGKV1D-12/IGKV1D-16|8|AIYMHQEPSSLSASVGDRVTITC|IGKV1-6|3|DGDFKVY|IGLV7-46|5|WYQQKPGKAPKLLIF|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>zigakibart_VL|KASQNVGNNVA|IGKV3-15/IGKV3D-15|5|DIVMTQSPSTLSASVGDRVTITC|IGKV1-5|1|SASNRDS|IGKV2-30|2|WYQQKPGKAPKLLIS|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>zilovertamab_VL|RASKSISKYLA|IGKV1-16/IGKV1-27|3|DIVMTQTPLSLPVTPGEPASISC|IGKV2-40/IGKV2D-40|0|SGSTLQS|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGQAPRLLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|0
>ziltivekimab_VL|RASQGISSWLA|IGKV1-12/IGKV1D-12/IGKV1D-16|0|DIQMTQSPSTLSASVGDRVTITC|IGKV1-5|0|KASTLES|IGKV1-27/IGKV1-8/IGKV1-9/IGKV1D-8|2|WYQQKPGKAPKVLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|1
>zimberelimab_VL|TGTSSDVGFYNYVS|IGLV2-11/IGLV2-14/IGLV2-8|1|QSALTQPASVSGSPGQSITISC|IGLV2-14/IGLV2-23|0|DVSNRPS|IGLV2-11|1|WYQQHPGKAPELMIY|IGLV2-11/IGLV2-14/IGLV2-23/IGLV2-8|1
>zinlirvimab_VL|GRQALGSRAVQ|IGLV3-12|6|SYVRPLSVALGETARISC|||NNQDRPS|IGLV1-40|3|WYQHRPGQAPILLIY|IGKV3-11/IGKV3-15/IGKV3-20/IGKV3D-11/IGKV3D-15/IGKV3D-7|3
>zolbetuximab_VL|KSSQSLLNSGNQKNYLT|IGKV4-1|5|DIVMTQSPSSLTVTAGEKVTMSC|IGKV2-28/IGKV2D-28|7|WASTRES|IGKV4-1|0|WYQQKPGQPPKLLIY|IGKV4-1|0
>zovostotug_VL|RASQSISSYLN|IGKV1-39/IGKV1D-39|0|DIQMTQSPSSLSASVGDRVTITC|IGKV1-16/IGKV1-17/IGKV1-27/IGKV1-33/IGKV1-39/IGKV1-NL1/IGKV1D-16/IGKV1D-33/IGKV1D-39|0|AASSLQS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|0|WYQQKPGKAPKLLIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|0
>zuberitamab_VL|RASSSVSYMH|||DIELSQSPAILSASPGEKVTMTC|IGKV1-9|8|APSNLAS|IGKV1-12/IGKV1-16/IGKV1-17/IGKV1-39/IGKV1-6/IGKV1D-12/IGKV1D-16/IGKV1D-17/IGKV1D-39|3|WYQQKPGSSPKPWIY|IGKV1-12/IGKV1-33/IGKV1-39/IGKV1-5/IGKV1-6/IGKV1-8/IGKV1-9/IGKV1D-12/IGKV1D-13/IGKV1D-33/IGKV1D-39|4
(1018 rows)
